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1 Introduction 
Due to increasing worldwide problems with bacterial resistance, the use of 
antibiotics in veterinary medicine has entered the public eye (Johns et al. 2012). 
Despite fierce discussions, there has not been a lot of research on the necessity 
of the perioperative application of antibiotics in equine surgery. In addition to 
bacterial resistance developing against antimicrobial agents, antibiotic 
prophylaxis can also cause adverse effects in horses such as diarrhoea and/or 
colitis (Weese and Cruz 2009). Information on an ideal perioperative 
antimicrobial agent for equines is not available (Weese and Cruz 2009, 
Southwood 2014) although penicillin and gentamicin are widely used in 
combination (Southwood 2014).  
German guidelines on antibiotic use in animals specify, that complicated and 
long surgical procedures should be the sole indication for antibiotic prophylaxis in 
horses (Bundestierärztekammer 2015). In clean orthopaedic surgeries of equines, 
in the 1980s, an infection rate of 8.1% was shown (MacDonald et al. 1994). 
However, rates close to 1% for the development of – potentially life-threatening – 
septic arthritis after arthroscopy was reported in newer studies (Olds et al. 2006, 
Borg and Carmalt 2013). Despite overall low infection rates in clean arthroscopic 
procedures, many equine surgeons still prefer to administer pre-/perioperative 
antimicrobials due to the severe consequences of a joint infection (Borg and 
Carmalt 2013). However, each use of antimicrobials will feed the development of 
resistant bacterial strains, development of superinfections, and nosocomial 
infections (Olds et al. 2006). Especially for clean procedures in veterinary 
medicine, further research is needed on the necessity of antimicrobial 
prophylaxis because its benefit still remains unclear (Weese 2008).  
The aim of the two studies presented here was to elucidate possible differences 
in the complications developing in horses undergoing clean, elective, orthopaedic 
surgical procedures, whether receiving pre- or perioperative antimicrobial 
prophylaxis or not.  
2 
2 Literature survey 
2.1 Perioperative antimicrobial prophylaxis 
Nosocomial infections are a widespread problem: According to a study on 
antibiotic prophylaxis in humans at 72 German hospitals, 3.5% of all patients 
develop a hospital-acquired infection, of which approximately 15% occur at 
surgical sites (Ruden et al. 1997). The proliferation of bacteria will be suppressed 
when antibiotics are administered before the tissue is contaminated (Burke 1961). 
According to Cruse and Foord (1980), wounds are classified as clean, clean-
contaminated, contaminated, or dirty. In a ten-year prospective clinical study of a 
total of 62,939 wounds, an infection rate of 1.5% was determined for 47,054 
wounds classified as “clean”. In dirty wounds (2,093), defined by the presence of 
pus, a perforated viscus, or a traumatic wound older than four hours, the infection 
rate reached 40% (Cruse and Foord 1980). Nowadays, the administration of 
prophylactic antibiotics for arthroscopy in humans is no longer recommended. 
However, an antibiotic prophylaxis in human orthopaedic surgery is still indicated 
when implants remain in the body (Széll et al. 2006). On the other hand, a recent 
prospective randomised controlled study of antimicrobial prophylaxis in 100 
patients undergoing lesser toe fusion surgery with K-wire implants did not find 
any significant difference between a wound infection developing in antibiotic-
receiving (6.2 % infection rate) and in control (1.9% infection rate) patients 
(Mangwani et al. 2017). 
The timing of an antibiotic application is critical because it is mandatory to have 
sufficient drug levels in the tissue where the antibiotic concentration must exceed 
90% of the minimum inhibitory concentration (Kujath et al. 2006). Using β-lactam 
antibiotics for prophylaxis, the administration has to be timed between one hour 
prior to surgery and making the initial incision (Burke 1961, Classen et al. 1992). 
Already in 1992, the incidence of surgical site infections in patients receiving 
antibiotics two to three hours prior to surgery or 24 hours after surgery, was more 
than twice as high than in patients being treated during two hours before and 
three hours after the initial incision (Classen et al. 1992). A retrospective analysis 
of 5,023 case files of paediatric surgery, including general, cardiac, or spinal 
3 
surgery, found a 1.7-fold higher risk of developing a surgical site infection (SSI) 
when administering perioperative antimicrobial prophylaxis incorrectly (Shah et al. 
2014).  
As the tissue drug levels need to remain effective in longer surgeries, a repetition 
dose might be necessary. Administering a repetition dose after two half-lives of 
the pharmacon seems reasonable (Kujath et al. 2006). A repetition dose is not 
necessary in orthopaedic surgeries that do not exceed three hours (Széll et al. 
2006). A benefit of continuing an antimicrobial prophylaxis after wound closure 
was not brought to proof (Dellinger et al. 1994).  
Although a lot of information has been provided on a correct perioperative 
antimicrobial prophylaxis in human medicine (Hohmann et al. 2012), individual 
differences in the timing and duration of antibiotic prophylaxis cannot be denied 
(Martin and Pourriat 1998). A study of 5,064 surgeries conducted at seven 
German clinics indicates, that the guidelines for perioperative antimicrobial 
prophylaxis were followed in 70.7% of all the cases (Hohmann et al. 2012). 
During a prospective clinical study which monitored the perioperative 
antimicrobial prophylaxis conforming to the guidelines, there was a significant 
increase in the correct timing of the first antibiotic dose, and the excessive 
duration of perioperative antimicrobial prophylaxis (in 1,187 procedures) was 
significantly reduced compared to four months prior to the study (1,211 
procedures). Full compliance with the guidelines was achieved in 40.2% of the 
cases. This was significantly higher (15.5%) than before the study. Also, the 
incidence of surgical site infections dropped from 18.5% to 12.0% (Bozkurt et al. 
2013).  
Boaz et al. (2014) conducted a single-centre, cross-sectional study to compare 
the incidence of complications prior to and following implementation of the 
Guidelines for Safe Surgery checklist. After introducing this checklist, 
postoperative fever was reduced significantly from 10.6 to 5.3%. Furthermore, 
the incidence of surgical site infections decreased by 34%, though this was not 
significant (Boaz et al. 2014).  
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Several guidelines define the risk factors for developing a surgical site infection in 
humans. For example, advanced age is mentioned as well as extremes in 
nutritional status, diabetes, colonization of the nasal vestibule with 
Staphylococcus aureus, coexisting infection at a remote body site, altered 
immune response, and preoperative hospitalization (World Health Organization 
2009, Wacha et al. 2010, Bratzler et al. 2013). The surgery-associated risk 
factors listed are inadequate skin preparation, inappropriate preoperative 
shaving, inadequate surgical team hand and forearm antisepsis, contaminated 
operating room environment, inappropriate surgical attire and drapes as well as 
inadequate sterilization of instruments, excessive duration of the surgery, poor 
surgical technique, and inappropriate or untimely administered antimicrobial 
prophylaxis (Wacha et al. 2010, Bratzler et al. 2013). In creating wounds in 
equines, the surgeons themselves are the proximate cause of bacterial 
contamination by the surgical incision (Santschi 2006). Usually, the nasal 
vestibule is the reservoir for methicillin-resistant Staphylococcus aureus (MRSA), 
but the hands of medical personnel may also transfer bacteria, for example after 
contact to contaminated patients and surfaces. In German human hospitals, 
MRSA-positive personnel are asked to refrain from treating or taking care of the 
patients (Robert Koch Institut 2016). Also, surgical theatre clothes should be 
changed regularly. On their surface was higher contamination after being worn 
for two hours than initially. This suggests that the skin flora is carried over from 
the body to theatre clothing. A definite limit of time for wearing the clothes cannot 
yet be given because this requires further research (Sivanandan et al. 2011) but 
a regular change of theatre clothes apparently is indicated. 
In equine surgery, there is no information on the ideal antibiotic agent although a 
combination of penicillin and gentamicin is used regularly (Southwood 2014). For 
colic surgery, in 23 German equine hospitals, a combination of penicillin and 
gentamicin (34.8%) was most commonly used, followed by penicillin alone 
(21.7%), cefquinome (8.7%), marbofloxacin (4.3%), sulfonamide/trimethoprim 
(4.3%), amoxicillin and gentamicin (4.3%), and amoxicillin alone (4.3%) 
(Teschner et al. 2015). 
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In equine castrations, the contamination of the wounds cannot be avoided as 
covering these wounds to avoid direct contact with bacteria, e.g. during lying 
down, is practically not possible. The increase of serum amyloid A (SAA) in 
castrates that received penicillin additionally to an NSAID (n=24) was not as 
great as in horses without perioperative antimicrobial prophylaxis (n=26, Busk et 
al. 2010). Another study concerning equine castrations (n=47) showed that a 
three day course of intramuscular procaine penicillin (n=23) was more effective 
than a single shot of intravenous penicillin G sodium (n=24) in reducing post-
surgical scrotal swelling, wound drainage and body temperature on day 8 after 
surgery. Also, β-haemolytic Streptococcus spp. was found more frequently in the 
single shot group (Haucke et al. 2017).  
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2.2 Antibiotic resistance – a worldwide emerging health 
concern 
2.2.1 Antibiotic resistance  
Antibiotics and chemotherapeutics are substances that inhibit bacterial growth. 
Typically, antibiotics are produced by fungi or bacteria for protection against 
other microorganisms. Chemotherapeutics are produced synthetically 
(Bundesministerium für Gesundheit et al. 2015). In the following, the term 
“antibiotic” refers to both, antibiotics and chemotherapeutics.  
Antibiotic resistance means that bacteria are not affected by antibiotics. This is 
subclassified in natural and acquired resistance (Kayser and Böttger 2010, 
Valentin-Weigand 2010). If strains of bacteria are not affected by an antibiotic 
agent because of a characteristic quality of their species/family, it is called 
natural resistance (Kayser and Böttger 2010). For example, the outer cell 
membrane of gram-negative bacteria is responsible for their resistance to β-
lactam antibiotics (Kroker et al. 2010). In the case of a genome change in 
primarily susceptible bacteria (Kayser and Böttger 2010) through mutations, 
transformation, transduction, and conjugation (Kroker et al. 2010, Valentin-
Weigand 2010), the antibiotic resistance is called acquired resistance. Through 
the so-called horizontal gene transfer, resistance can even be exchanged 
between different species of bacteria (Ventola 2015).  
Mechanisms of resistance include modification of target structures such as the 
penicillin-binding Protein 2a (PBP2a), which is the principle of resistance to β-
lactam antibiotics in MRSA and other coagulase-negative Staphylococcus 
species (Mallardo et al. 2013). Important as well is the enzymatic inactivation of 
the antibiotic and the minimisation of the intracellular concentration of the 
antibiotic by decreased influx and/or increased efflux (Kayser and Böttger 2010, 
Valentin-Weigand 2010).  
The clinical resistance is of major importance for the veterinarian. Bacteria are 
clinically resistant when they are not susceptible to the concentration of the 
antimicrobial that can be reached in the tissue (Kayser and Böttger 2010). 
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Antibiotic resistance emerged even before the antibiotic era (D'Costa et al. 2011). 
Scientists confirmed a connection between the 30,000-year-old VanA, which is 
the enzyme responsible for resistance to vancomycin and the structures found in 
present-day bacteria (Courvalin 2006, D'Costa et al. 2011). Whenever 
antimicrobials are used, resistant bacteria obtain a selective advantage (Kayser 
and Böttger 2010, Kroker et al. 2010, Valentin-Weigand 2010, Mather et al. 
2013). The spread of resistance, despite the development of new antimicrobials, 
is not only a question of mutation and horizontal gene transfer but also a 
question of the frequency and prudence of the new drug substance’s use 
(D'Costa et al. 2011). Therefore, a reasonable administration is important for 
maintaining the effect of antibiotic agents (Hughes et al. 2013). 
2.2.2 Antibiotic resistance in humans 
In the United States of America, more people die each year from infections 
caused by MRSA than from HIV/AIDS, Parkinson’s disease, emphysema, and 
homicide combined. The first MRSA was isolated in the United Kingdom (Ventola 
2015), 34 years after the discovery of Penicillin by Sir Alexander Fleming in 1928. 
Another 53 years later, infections with antimicrobial resistant bacteria have 
become a global problem (Ventola 2015). 
The administration of antibiotic agents is an important component of modern 
therapies, for example, in neonatal care or in organ transplantations (Perez and 
Villegas 2015). As patients are weakened through disease or surgical procedures, 
infections in hospitals are typically caused by resistant bacteria (Ventola 2015). 
The on-going distribution of bacterial strains resistant to most or even all 
available agents underlines the need for progress in the development of new 
antimicrobial agents and, most of all, the prudent use of available antibiotics 
(Perez and Villegas 2015).  
A high risk of getting infected with multi-drug resistant bacteria, other than the 
consumption of antibiotics or hospitalization, has been attributed to travel to 
Africa and Greece as well as to having had contact with pets (Schmiedel et al. 
2014). MRSA has been isolated from both companion animals and livestock 
(Loncaric et al. 2014). Coagulase-negative staphylococci that were isolated from 
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animal infection sites turned out to be the same species as those causing 
nosocomial infections in humans (Kern and Perreten 2013). Interestingly, isolates 
from cats, dogs, and horses typically belong to human Staphylococcus aureus 
lineages, whereas farm animals are infected with non-human MRSA strains 
(Loeffler and Lloyd 2010, McCarthy et al. 2012). Resistance to ertapenem, an 
antimicrobial that is not approved for use in livestock and only restrictedly 
allowed in companion animals, was found in several isolates of 19.7% of the 
animals (35/178) and 24.5% of the humans (45/183). Of these isolates, 95.6% 
were segregated from cats and dogs, which suggests that these bacteria have 
been transferred from owner to pet (Schmiedel et al. 2014). For animals, 
repeated admission to a veterinary practice/hospital and usage of antimicrobials 
were noted as a risk factor to obtain MRSA. For humans and animals living in the 
same household with an MRSA carrier, hospitalization and surgery increase the 
risk of MRSA acquisition (Weese et al. 2006).  
Furthermore, antibiotic resistance is also of great immediate political interest. 
During the G7-summit in 2015, the G7-states agreed on supporting the global 
action plan of the World Health Organization concerning antibiotic resistance as 
well as on developing national action plans. Furthermore, they will promote 
research in the area of epidemiology, infection prevention and control, as well as 
the development of new antibiotics, alternative therapies, vaccines, and rapid test 
(G7-Gipfel 2015).  
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2.2.3 Antibiotic resistance in horses 
With antibiotic resistance considered to be one of the most severe developing 
worldwide health concerns, the antibiotic use and resistance in veterinary 
medicine are subject to public (Johns et al. 2012) and political attention (G7-
Gipfel 2015). However, the focus of antibiotic resistance in veterinary medicine is 
rather on production animals than on horses (Bundesamt für Verbraucherschutz 
und Lebensmittelsicherheit und Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. 
2016, Bundesamt für Verbraucherschutz und Lebensmittelsicherheit 2016, 
Bundesministerium für Gesundheit et al. 2015), but antibiotic use in horses was 
restricted as well with the latest novella of the ”Verordnung über tierärztliche 
Hausapotheken (TÄHAV)”. For any off-label use of an antibiotic in horses, or the 
administration of third and fourth generation cephalosporins and fluorquinolones, 
a bacteriological culture including an antibiogram is mandatory (TÄHAV § 12 c).  
Development of resistant bacteria during a course of antibiotic treatment was 
shown previously. A study performed at a veterinary teaching hospital indicated 
that 21.9% of the participating horses (n=105) had developed nosocomial gram-
negative aerobic infections with high rates of resistance against three of the most 
frequently prescribed antibiotics gentamicin, kanamycin, and trimethoprim/ 
sulfadiazine. Escherichia coli and Klebsiella sp. isolated on day 7 were resistant 
to a significantly higher number of antibiotics than day 1 isolates (Koterba et al. 
1986). A newer study also examined the faecal samples of 32 horses admitted to 
hospital: 13/32 horses were treated with antimicrobial agents prior to admission, 
and 21/32 horses were treated with antimicrobial agents during their 
hospitalization. In these horses, significant alterations in specific in-vitro equine 
faecal E. coli antimicrobial resistance profiles were found after hospitalisation for 
7 days. Also, multi-drug resistant E. coli were isolated significantly more often 
after 7 days of hospitalisation (Williams et al. 2013).  
Not only in a hospital but also in the field, an elevated risk of developing 
commensal E. coli resistant to antimicrobials was found in horses treated with 
antibiotics. Enrolled in this study were 80 horses: 56 were hospitalised and 
treated with antibiotics, 14 were not hospitalised and treated with antibiotics, and 
10 were not treated with antibiotics and hospitalised (control). Samples were 
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collected within 24 hours of admission/first treatment, five days after 
admission/initiation of treatment, two weeks after discontinuation of the antibiotic, 
and six weeks thereafter. There was no significant difference between 
hospitalised and non-hospitalised horses. The odds of a sample to contain a 
resistant isolate increased significantly on day 5 in the treated horses, but not in 
the controls. Two weeks after discontinuation, the odds to identify a resistant 
isolate returned to baseline in the non-hospitalised horses, but not in the 
hospitalised horses in which resistant bacteria were significantly more often 
isolated than before treatment. Pre-treatment levels were reached two months 
after the treatment in the antibiotic receiving, hospitalized horses (Johns et al. 
2012).  
A survey in the United Kingdom showed that over 60% of the antibiotics 
prescribed were not dosed correctly. 56.9% of the antibiotics were dosed too 
high, whereas 5.8% were given under the recommended dose (Hughes et al. 
2013). In Germany, Austria, and Switzerland the selected dosage for antibiotics 
is insufficient in 12 % (manufacturer data) – 72 % (BEVA recommendations, 
https://www.beva.org.uk/protectme). These data suggest, that in these countries 
veterinarians rather follow manufacturer’s data than scientific information 
(Schwechler et al. 2016). It must be considered problematic, that label dose 
instructions are not always consistent with current principles of prudent 
antimicrobial use and may promote antimicrobial resistance (Weese et al. 2015). 
Antimicrobial resistance is a critical issue in equine medicine. Strategies for the 
adequate use of antibiotics need to be developed (Bowen 2013). As a pioneer, 
the British Equine Veterinary Association (BEVA), developed the “Protect ME”-
strategy to improve antibiotic use in equine medicine and to encourage the 
introduction of “Responsible antibiotic use policies” in every practice (British 
Equine Veterinary Association 2018). 
Therefore, the aim of this research project was to confirm the hypothesis that 
perioperative antimicrobial prophylaxis does not lead to a reduction in post-
operative infection in equine clean elective uncomplicated orthopaedic surgery. 
This should contribute to the targeted use of antibiotics and at least help to 
decrease the progression of antibiotic resistance.  
11 
2.3 Equine acute phase parameters 
As a protective mechanism, the inflammatory reaction dilutes, isolates, and at 
best eliminates the cause of tissue damage and repairs the defect through 
healing. This is the body’s own capacity to react to endogenous and exogenous 
noxae. The five cardinal signs (tumour, rubor, dolour, calor, functio laesa) of an 
inflammatory reaction are commonly known (Ackermann 2009) but not always 
clinically visible (Jacobsen and Andersen 2007).  
Proteins whose plasma level increase/decrease during an inflammation by ≥ 25%, 
are called acute-phase proteins. These proteins are mainly synthesized in the 
liver and mediate or inhibit the inflammatory reaction (Jain, Gautam, and Naseem 
2011; Baumgärtner and Schmitt 2010; Ackermann 2009). Production of Serum 
Amyloid A (SAA), C reactive protein (CRP), and haptoglobin can also be found in 
the lungs (Yang et al. 1995, Ramage et al. 2004, Upragarin et al. 2005). During 
inflammation, in many species the plasma concentrations of CRP, α1-acid 
glycoprotein, haptoglobin, mannose-binding protein, fibrinogen, and α1-
antitrypsin, as well as the concentration of the complement factors C3 and C4 
augments, whereas the concentration of albumin and prealbumin decreases 
(Ackermann 2009). Ferritin, transferrin, and ceruloplasmin are also mentioned as 
acute phase proteins (Baumgärtner and Schmitt 2010). 
Besides SAA and fibrinogen, haptoglobin has been reported to be an important 
acute phase parameter in horses (Taira et al. 1992).  
2.3.1 Serum amyloid A 
As the major acute phase protein in horses, the heterogeneous apolipoprotein 
(Uhlar et al. 1994) serum amyloid A is a reliable parameter of inflammation or 
infection in the horse (Baumgärtner and Schmitt 2010, Belgrave et al. 2013). 
Beside the synthesis in liver and lungs, the mammary gland (colostrum) and 
joints were found to produce SAA (McDonald et al. 2001, Jacobsen et al. 2006). 
SAA concentrations in the serum of foals diagnosed with bacterial infections (n=8) 
were reported to be higher than in foals with non-bacterial or uncertain diagnosis 
(n=17) (Hulten and Demmers 2002). The degradation of SAA takes place in the 
liver (Bausserman et al. 1987). Its plasma half-life is very short; in laboratory 
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rodents, it reaches from 30 to 120 min (Hoffman and Benditt 1983, Uhlar and 
Whitehead 1999). Approximately six hours after the onset of inflammation, the 
plasma level of SAA starts increasing by more than a hundred-fold (Jacobsen 
and Andersen 2007). The maximum plasma level is reached 48 hours after the 
triggering stimulus (Jacobsen and Andersen 2007). The kinetic profile and 
diagnostic sensitivity make it an ideal marker for inflammation and tissue damage 
in the horse (Crisman et al. 2008). It is possible that the pattern of expression is 
regulated by different inflammatory stimuli (Raynes and McAdam 1991, Rygg et 
al. 1993). Reactions to SAA include enhancement or inhibition of leukocytes, T 
cell chemotaxis (Xu et al. 1995), inhibition of proliferation of endothelial cells and 
lymphocytes, inhibition of platelet aggregation, and phagocytosis (Crisman et al. 
2008). During inflammation, the observed intra-articular synthesis of serum 
amyloid A could lead to the induction of metalloproteinase activity and 
cyclooxygenase metabolite formation as well as to a chemical attraction of 
leukocytes (Badolato et al. 1994, Malle et al. 1997, Vallon et al. 2001, O'Hara et 
al. 2004).  
Non-infectious arthritis was induced by aseptic injection of amphotericin B (20 mg) 
and sterile water (4 ml) into the right mid-carpal joint of 24 horses. 16 hours after 
injection, all horses had elevated SAA concentrations which returned to baseline 
within 15 days. In this study, the relative maximum increase of SAA was 
significantly higher than that of the other markers (haptoglobin, fibrinogen, α2-
globulin (Hulten et al. 2002). After an intrasynovial injection of 1 µg or 3 µg LPS 
diluted in 2 ml saline, respectively, the serum and synovial fluid SAA levels 
peaked 48 hours after injection and then declined rapidly. The SAA response 
depended on the LPS dose injected into the joint: 1 µg LPS was found to cause 
lower SAA levels than 3 µg LPS (Jacobsen et al. 2006). Comparing the white 
blood cells (WBC) and SAA concentrations after initiating the non-infectious 
arthritis, the WBC showed an earlier augmentation (4-8 hours after induction) 
and peak (12 hours after induction). The course of WBC reflected the clinical 
signs with a return to the base-level 48-72 hours after initiating the inflammation. 
The SAA peaked 48 hours after arthritis induction when the clinical signs started 
to disappear. Despite its quick decline, the augmented levels of SAA lasted 
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distinctly longer than the leucocytosis and levels were back to baseline level after 
144 hours (Jacobsen et al. 2006).  
In 24 horses undergoing arthroscopies, the SAA peaked twelve hours after the 
procedures. Seven days after surgery, the SAA concentration returned to its 
reference interval (Miller 2006). Another study measuring the inflammatory 
response after arthroscopy (n=11) found significantly higher levels than the 
preoperative baseline levels of SAA on the first day after surgery. Baseline levels 
were again reached five days after surgery (Jacobsen et al. 2009).  
2.3.2 Fibrinogen 
Beside its role in the coagulation process, several functions have been attributed 
to the plasma glycoprotein fibrinogen (Crisman et al. 2008). Due to its relatively 
high concentrations in healthy individuals (200-400 mg/dl) and the lengthy 
response period, fibrinogen is regarded as a fairly insensitive acute-phase 
protein. 24-72 hours after being exposed to an inflammatory stimulus, the plasma 
fibrinogen concentrations show a 1-10-fold increase (Crisman et al. 2008). The 
peak concentration is reached after 72-144 hours (Jacobsen and Andersen 
2007). The augmentation remains elevated for up to 7 days after the end of the 
inflammation (Crisman et al. 2008) and is, therefore, not as sensitive as SAA as 
an inflammatory marker. Degranulation, phagocytosis, and antibody-dependent 
cytotoxicity as a result of an intracellular signal cascade after binding to CD11 
and CD18 (cell surface integrins) are attributed to this β-globulin (Crisman et al. 
2008).  
Thirty-six hours after the induction of arthritis by injection of 20 mg Amphotericin 
B into the right mid-carpal joint of 24 horses, all probands had increased serum 
fibrinogen levels. These concentrations returned to normal levels after 15 days 
(Hulten et al. 2002). 
After arthroscopy in eleven horses, fibrinogen concentrations were significantly 
higher on day one than preoperatively. The fibrinogen concentration remained 
elevated throughout the eleven day observation period of the study (Jacobsen et 
al. 2009). Another study examining the response of 24 horses undergoing an 
arthroscopy found a significant increase of fibrinogen concentration 24 hours 
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after surgery, which was even more distinct 48 hours after surgery (Miller 2006). 
Like SAA, it declined to normal levels after 7 days (Miller 2006).  
2.3.3 Iron 
The plasma iron concentration decreases in horses during systemic inflammation 
(Feldman et al. 1981, Smith and Cipriano 1987, Borges et al. 2007). After 
lipopolysaccharide infusion, less iron enters the circulation due to hepcidin, which 
prevents the export from the mononuclear phagocytic system and from 
enterocytes (Oliveira-Filho et al. 2012). In mice, the iron resorption from the gut is 
also affected by hepcidin as a negative regulator (Nicolas et al. 2001, Pigeon et 
al. 2001). In mammals, iron is important for oxygen transport, phagocytosis, and 
the mitochondrial electron transport chain (Marx 2002). Iron is essential for 
bacterial proliferation (Marx 2002) and viral replication as part of the 
ribonucleotide reductase (Drakesmith and Prentice 2008). During infection, host 
and microbe require iron, so they compete for the host’s iron stores. As a 
response to inflammation and chronic infection, iron sequestration is a well-
recognized defence mechanism which leads to hypoferraemia and anaemia 
(Kent et al. 1994, Weinberg 1996). Hypoferraemia and anaemia are common 
symptoms of this iron sequestration, which is a well-recognized defence 
mechanism of the host (Brosnahan et al. 2012). On the day after arthroscopy, the 
iron concentration decreased significantly in eleven horses but returned to 
baseline level the next day. Post-surgical iron concentrations were also affected 
by the patient’s age with older horses having higher iron levels (Jacobsen et al. 
2009). 
2.3.4 Haptoglobin 
The α2-globulin haptoglobin can be consistently detected in equine blood. Its 
concentrations are increased during inflammation (Jacobsen and Andersen 2007, 
Cray and Belgrave 2014). The function of the α2 globulin is to prevent iron loss. It 
forms stable complexes with the free haemoglobin in the blood. Free 
haemoglobin stimulates the synthesis of haptoglobin so that it can be collected 
efficiently, which prevents the loss of iron and limits the oxidative damage to 
tissue caused by free haemoglobin. The complexes formed by haptoglobin and 
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haemoglobin reduce the renal filtration of both haemoglobin and iron. These 
complexes are removed by hepatocytes allowing the reutilization of iron and 
amino acids so that the components can be reused. It is also believed that 
haptoglobin has a bacteriostatic effect since it limits the availability of iron which 
is essential for bacterial growth (Crisman et al. 2008). During the acute phase 
reaction, it shows a 1-10-fold augmentation and is therefore considered a 
moderate acute-phase protein (Crisman et al. 2008). The concentration of free 
haptoglobin can be affected by events other than inflammation such as acute 
haemolysis, during which its plasma concentration decreases (Crisman et al. 
2008). 
After inducing non-septic arthritis by injecting 20 mg Amphotericin B into the right 
mid-carpal joint of 24 horses, the relative haptoglobin concentration increased 16 
hours after injection. An absolute increase was observed 24 hours post-injection. 
The peak in haptoglobin concentration was observed three days after induction 
of the non-infectious arthritis. On day five, the mean haptoglobin concentration 
returned to the reference interval (Hulten et al. 2002). A recent study examined 
haptoglobin as an inflammatory parameter in serum and synovial fluid. Non-
septic arthritis was induced in 12 Shetland-pony geldings with 25 mg 
amphotericin B which was diluted in 3 ml of sterile water and injected aseptically 
into one radio-carpal joint. Prior to arthritis induction, the haptoglobin in the serum 
was significantly higher than in the synovial fluid (p=0.0021). Both in the serum 
and synovial fluid, the haptoglobin concentration was significantly higher 15 days 
after inducing non-septic arthritis than before (p<0.0001). Fifteen days after 
injecting the amphotericin B, the concentration of haptoglobin in the serum was 
not significantly higher than in the synovial fluid (Barrachina et al. 2016).  
After arthroscopy in 24 horses, the haptoglobin concentration showed a slight 
increase after 48h as well as a decisive augmentation after 72 h (Miller 2006). 
Whereas these values decreased seven days after arthroscopy, they continued 
to increase in horses that were castrated and suffered from wound healing 
disturbance (n=12) as well as in horses that underwent laparoscopy (n=27) 
(Miller 2006).  
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2.3.5 Albumin  
Albumin is a 66 kDa protein that is invariably found in plasma (Gassmann and 
Lutz 2005). 60% of the plasma protein fraction is albumin (Horn et al. 2005). The 
protein without a prosthetic group is mainly responsible for maintaining the 
oncotic pressure and also for unspecific transport (e.g., bilirubin, fatty acids, 
bivalent cations) (Gassmann and Lutz 2005). The concentration of albumin 
decreases during the acute phase of an inflammation (Ackermann 2009, 
Baumgärtner and Schmitt 2010); therefore, it is a so-called negative acute phase 
protein. However, in 24 horses undergoing arthroscopy, the albumin 
concentration increased by 1% over 7 days (Miller 2006).  
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3 Material and methods 
3.1 Retrospective data analysis 
The aim of the retrospective part of this study was to evaluate whether or not an 
antibiotic prophylaxis was able to decrease surgery-associated complications in 
elective, clean equine orthopaedic surgery. 
3.1.1 Data collection 
Electronic patient charts (easyVET, IFS Informationssysteme GmbH/Hannover, 
Germany) were reviewed of horses that underwent an elective, clean orthopaedic 
surgery at the equine clinic in Lüsche (Tierklinik Lüsche GmbH, Bakum, 
Germany) between June 8th, 2011, and January 9th, 2015 (3 years and 7 months). 
June 8th, 2011 was chosen as a starting point because from that time on, a 
special record of horses that did not receive antimicrobial prophylaxis before the 
elective surgery was started at Tierklinik Lüsche GmbH. The start of the 
prospective study (see section 3.2) determined the end of the retrospective study.  
3.1.2 Study population  
All data of horses that underwent elective, clean orthopaedic surgery were 
considered for inclusion in the retrospective analysis. Arthroscopy, fasciotomy, 
neurectomy, tendovaginoscopy, tenotomy, extraction of fractured splint bones 
(Mc II, Mc IV, Mt II, or Mt IV), bursoscopy, and combinations of these were 
defined as elective, clean orthopaedic surgeries. Documentation was considered 
complete if information was available about the pre-anaesthetic examination on 
the day prior to the operation, as well as the type of surgery, the number of 
operated joints/legs, the antimicrobial usage, and the antibiotic agent applied. 
Case files with incomplete documentation were not considered for statistical 
evaluation. Horses that had contracted a disease not associated with the surgery 
or which had already left the hospital on the day of surgery were not included. 
Patients that were euthanized during surgery due to irreparable findings (e.g. 
extreme cartilage destructions) were also not incorporated in the retrospective 
study. 
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3.1.3 Data extraction 
The case details extracted comprised signalment, type, year, and season of the 
surgery, as well as the number of legs/joints operated on. The horses included in 
the statistical evaluation stayed for at least one night after surgery. At the 
discharge of each patient, the clinic asked the owners to contact them when 
complications occurred. The data were noted on antibiotic usage and any 
substances used as well as on the time and type of complications. The veterinary 
surgeon in charge decided on the antibiotic treatment based on his personal 
experience and preferences. 
Complications included joint/wound infections, neuroma and seroma, 
dehiscence, any kind of wound discharge and its character, moderate and severe 
swelling as well as fever and inflammation of the subcutaneous tissue. Therefore, 
details were necessary of the regular surgical wound evaluation during bandage 
changes and the daily measurement of the rectal temperature. Fever was 
defined as a rectal temperature of at least 38.6°C – at this temperature, the 
horses were not only monitored more closely, but also received additional 
medications. Fever was either listed as being the sole postoperative complication 
or occurring associated with a complication at the surgical site or associated with 
alterations at the incision site plus suspected respiratory/gastroenteric disease.  
The responsible orthopaedic surgeon and assistants were noted for all surgeries. 
Veterinarians that had participated in less than 30 surgeries were merged into 
one group for statistical analysis. The duration of postoperative hospitalisation 
and outcome was also excerpted. Possible outcomes were discharge from the 
clinic, second orthopaedic surgery, or euthanasia due to surgery-related 
complications. If available, the white blood cell count of the day prior to surgery 
was extracted from the patient file as well.  
The information was manually transferred from the patient chart into an excel file. 
After checking it twice, the data was encoded for the statistical analysis. For this 
purpose, antibiotic agents belonging to the same class, as well as agents and 
combinations of those with a similar spectrum of efficacy, were listed together. 
Procaine-benzylpenicillin, procaine-benzylpenicillin plus dihydrostreptomycin, 
and amoxicillin were grouped together as “penicillin-based antibiotics”. If these 
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agents were combined with gentamicin, they were grouped as “gentamicin 
combined with penicillin-based antibiotics”. Also, the cephalosporins (ceftiofur, 
cefquinome, and cefalexin) were incorporated into the group “gentamicin 
combined with penicillin-based antibiotics” due to their expected broad spectrum 
efficiacy. Trimethoprim/sulfadiazines formed the third group. A fourth group 
consisted of other combinations such as gentamicin with 
trimethoprim/sulfadiazine or gentamicin with cefquinome. Antimicrobial treatment 
usually started on the evening prior to surgery. The second dose was maximally 
given six hours before induction of anaesthesia. Antibiotics were applied for 3-5 
days.  
3.1.4 Statistical analysis of the retrospective study 
The statistical assessment of the data was supported by Dr. Klaus Failing and 
Marion Sparenberg from the Unit for Biomathematics and Data Processing, 
Justus Liebig University, Gießen/Germany.  
During the retrospective part of the study, the data were statistically compared of 
the two independent groups, (a) horses that underwent clean orthopaedic 
surgery and received antibiotics (the group with perioperative antibiotic 
prophylaxis: PAP) versus (b) horses without any application of antimicrobial 
drugs (control). The main target parameter was the rate of postsurgical 
complications. 
Most of the statistical tests were conducted using BMDP/Dynamic, Release 8.1 
(Dixon 1993) (Statistical Solutions Ltd., Cork/ Ireland). For Fisher’s exact test and 
the exact Wilcoxon-Mann-Whitney test, StatXact-9 (9.0.0, Cytel, Cambridge, 
Massachusetts/USA) (Cytel 2010) was additionally used. The Fisher’s exact test 
was conducted when there were any differences in qualitative parameters 
between the horses receiving antibiotics and the controls, such as the 
occurrence of complications and the occurrence of exudation and its character. 
Furthermore, the Fisher’s exact test was applied to determine possible 
differences between the groups and the types of surgery, surgeon and assistant, 
and the year and season of surgery. This test was also used to detect differences 
in types of complications, development of fever, the outcome as well as gender 
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and breed between the treated animals and the controls. The Wilcoxon-Mann-
Whitney test was used to determine the differences between the groups in 
quantitative parameters like hospitalisation time, the day after surgery on which 
complications arose as well as the age of the horses. The exact Wilcoxon-Mann-
Whitney test was applied to determine differences between the PAP and control 
patients in the number of joints/legs operated on and the severity of the 
complication. 
Additionally, a multifactorial ANOVA was performed which considered the overall 
effects of possibly influencing variables like the kinds of surgical procedures, the 
number of surgical lesions, the surgeon, and the season. 
Microsoft® Excel® for Mac 2011 (Version 14.5.2) was used for graphically 
presenting the data. The mean ± standard deviation is given for describing the 
data when not mentioned otherwise. The significance level was set at p < 0.05 as 
usual.  
  
21 
3.2 Prospective clinical study 
The prospective part of the study was performed to compare the development of 
surgical site infections in equine clean orthopaedic surgery with and without 
antimicrobial prophylaxis. Except for the preoperative antimicrobial prophylaxis, 
the study participants followed the same medication and evaluation protocols. 
Another aim of the study was to evaluate the course of inflammatory parameters 
of the horses with and without preoperative antimicrobial prophylaxis and to 
evaluate their possible use as predictive and/or diagnostic parameters for 
surgical site infection. 
3.2.1 Study plan 
For this prospective randomized clinical trial, horses that underwent elective 
orthopaedic surgery were repeatedly examined over a period of seven days 
(Figure 1). To determine the number of animals needed per group, the Sample 
Size Calculator (http://clincalc.com/Stats/SampleSize.aspx) was used as a study 
power calculator. An expected complication rate of 8% was set for the 
antimicrobial-treated horses (MacDonald et al. 1994) and of 20% for the control 
group. The alpha value was set at 0.3, and the statistical power as 60%, with the 
result of a minimal sample size of 28 horses per group. The horses were 
randomised into an antibiotic-receiving and a non-antibiotic-receiving (control) 
group. The probands were assigned to the groups with the help of a 
randomization list that was created beforehand in Microsoft® Excel® 2011 
(Version 14.5.2, Microsoft Corporation, Redmond, USA). Data were collected 
from mid January 2015 to October 2015. 
In comparison to the usual procedures in the clinic, no additional examinations or 
additional blood samples were taken, just the blood volume was increased to a 
total volume of 25-30 ml per sample. According to the relevant authority 
(Regierungspräsidium Gießen), at that time, the animal welfare laws in Germany 
therefore did not require an approval procedure. Owners were informed about 
the additional blood examinations, but only charged for the usual creatinine 
analysis. 
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The horses included were randomised on the evening prior to their surgeries. If 
there was more than one surgery per day, the patients were listed in the same 
succession as on the surgery plan. On July 6th, 2015, a second randomization list 
was created in order to reach the required number of horses in each group since 
15 horses had to be excluded from the study due to reasons mentioned in 
chapter “4.2.1.1 Drop-outs". The author has personally examined 60 of the 
horses. However, due to the end of the author’s internship at Tierklinik Lüsche 
GmbH in mid July 2015, two colleagues clinically examined the remaining 15 
horses, and the laboratory team (2 persons) of the clinic was responsible for the 
laboratory evaluation (Table 5). All persons involved became acquainted with the 
procedures in detail while the author was working at the clinic.  
The wounds were evaluated three times postoperatively on days 1, 3, and 5 
(Figure 1) according to the specific criteria of a scoring system prepared 
beforehand (see chapter 3.2.4.4).  
Also, the inflammatory parameters SAA, haptoglobin, iron, albumin, as well as 
total serum protein, were determined on the same days the wounds were 
evaluated. Due to the regular postoperative monitoring of creatinine at Tierklinik 
Lüsche GmbH (Figure 1), there were no additional venipunctures. A maximum of 
24 ml of blood was withdrawn per horse. The inflammatory parameters were 
determined at the central laboratory of the department of veterinary medicine of 
the Justus Liebig University, Gießen. 
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Figure 1: Timing of clinical and laboratory examinations in the prospective study 
IP: inflammatory parameters (SAA, haptoglobin, iron, albumin, total protein) 
Day -1 Day prior to surgery Pre-anaesthetic examination 
Haematology, Creatinine & IP 
Randomization 
 
Day 0 Day of surgery Pre-surgical check – up 
Surgical intervention 
Post-surgical check – up 
Postural control  
New bandage/wound evaluation  
2x rectal temperature 
Creatinine & IP 
Day 1 after surgery 
Day 2 after surgery Postural control  
2x rectal temperature 
Postural control  
New bandage/wound evaluation  
2x rectal temperature 
Creatinine & IP 
Day 3 after surgery 
Postural control  
1x rectal temperature 
Day 4 after surgery 
Day 5 after surgery Postural control  
New bandage/wound evaluation  
1x rectal temperature 
Haematology, Creatinine & IP 
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3.2.2 Study population 
The study population consisted of horses that were presented to the Tierklinik 
Lüsche for an elective orthopaedic intervention. The study probands had to be 
clinically healthy except for the orthopaedic reason for surgery. Horses with 
chronic disease such as RAO or PPID were considered clinically healthy when 
only mild abnormalities were detected in the clinical examination and/or 
haematology. The participating horses had to be at least three months old. 
Surgeries took place at the equine clinic in Lüsche (Tierklinik Lüsche GmbH) 
except for five surgical interventions that were performed at Sanakena (part of 
Tierklinik Lüsche GmbH), an orthopaedic clinic for horses with a rehabilitation 
centre attached in Pinneberg. At Tierklinik Lüsche GmbH, the interns had to 
rotate to Sanakena where the surgery protocols are the same as at Tierklinik 
Lüsche GmbH. These five surgeries were conducted during the author’s rotation 
to Sanakena. 
The same examination pattern was applied to all horses. This included the 
clinical examinations and the laboratory tests (Figure 1).  
Drop-out criteria were a contraction of a disease not associated with the surgical 
procedure, such as infection of the respiratory tract or a surgical colic. Horses 
that followed a different examination schedule or had their perioperative antibiotic 
protocol changed by the responsible surgeon during or directly after the 
procedure, were also dropped out of the study. If the horses required antibiotic 
treatment within the study period but not due to the above mentioned reasons,, 
they stayed in the study. Patients leaving the hospital less than five days after 
surgery were also dropped out. 
3.2.3 Medication protocol 
3.2.3.1 Antibiotics 
Patients in the antibiotic group received 10 mg/kg amoxicillin (Belamox®, bela-
pharm, Vechta, Germany) and 6.6 mg/kg gentamicin (Genta 100mg/ml, CP-
Pharma, Burgdorf, Germany). The drugs were administered once via an I.V. 
catheter, which was placed by the anaesthetist directly (< 1 min), prior to using it 
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to induce the general anaesthesia. Between the administration and the initial 
incision, 30 to 45 minutes passed. The horses of the control group were neither 
administered antibiotics nor a placebo.  
3.2.3.2 Analgesia 
Either phenylbutazone (Phenylbutariem® 100 mg/ml Suspension zum Eingeben 
für Pferde und Ponys, Ecuphar NV/SA, Oostkamp/Belgium) or meloxicam 
(Metacam® 15 mg/ml, Suspension zum Eingeben für Pferde, Boehringer 
Ingelheim, Ingelheim, Germany) were used. Study participants which were not 
considered for food production according to their equine passport received 2.5 
mg/kg phenylbutazone orally twice daily, which is the recommended 
maintenance dose of the manufacturer. Horses that were intended to possibly 
serve for food production received 0.6 mg/kg meloxicam orally once per day as 
recommended by the manufacturer. The medication started on the evening prior 
to surgery and ended on the morning of the fourth day after surgery.  
3.2.3.3 Anaesthesia 
At Tierklinik Lüsche GmbH and in Sanakena, a standardized anaesthesia 
protocol existed for orthopaedic surgeries, which was applied to all participants of 
the study. Before being taken to the induction room, a catheter (Braunüle® MT, 
B. Braun Vet Care GmbH, Tuttlingen/Germany) was placed in the jugular vein. 
One patient had both jugular veins thrombosed, and therefore, the catheter was 
placed in the right cephalic vein. Through the catheter, the horses received 0.4 
mg/kg xylazine (Xylazin 2%, CP Pharma, Burgdorf/Germany) while they were still 
in the stable. After being led to the induction box, the horses received 0.8 mg/kg 
xylazine (Xylazin 2%, CP Pharma, Burgdorf/Germany) and L-Polamivet® (MSD 
Tiergesundheit, Unterschleißheim/Germany). L-Polamivet® contains 
levomethadone (2.5 mg/ml) in combination with fenpipramide (0.125 mg/ml). The 
levomethadone was dosed at 0.05 mg/kg, which meant 2 ml of L-Polamivet® per 
100 kg. To induce a general anaesthesia, 2.2 mg/kg ketamine (Ketamin 10%, CP 
Pharma, Burgdorf/ Germany) and 0.08 mg/kg diazepam (Diazepam Ratiopharm®, 
Ratiopharm GmbH, Ulm/Germany) were given intravenously. The anaesthesia 
was maintained by inhalation of isoflurane (Isofluran CP®, CP Pharma, 
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Burgdorf/Germany) in oxygen (Westfalen AG, Münster/Germany) through an 
orotracheal tube. While the surgery field was being prepared antiseptically and 
during the orthopaedic procedure, patients received an infusion of isotonic 
sodium chloride solution (Isotonische Natriumchlorid-Lösung ad us. vet. B. 
Braun, B. Braun Vet Care GmbH, Tuttlingen/Germany). Dobutamine (Dobutamin-
hameln 5 mg/ml Injektionslösung, Hameln Pharma Plus GmbH, 
Hameln/Germany) was added to the solution when indicated. As a postoperative 
sedation, xylazine was used (0.2 mg/kg). After recovering from surgery, each 
patient received 200 ml of plasma prepared from horses owned by the clinic. The 
catheter was removed after the plasma transfusion. 
3.2.4 Clinical examinations  
3.2.4.1 Pre-anaesthetic health check 
The horses were stabled at the clinic for at least one day before the elective 
surgical procedure. Gender, weight and age of every patient was recorded. In the 
evening before the surgical intervention, the study participants were checked for 
posture, behaviour, and body condition. The oral mucous membranes were 
checked for colour, moisture, and capillary refill time. The conjunctival 
membranes and sclerae were examined for their colour and status of their 
vessels. Nostrils were inspected for abnormal discharge. The discharge was 
considered abnormal when it appeared other than mild and serous. The pulse 
was palpated at the facial artery and evaluated for frequency and quality. The 
mandibular lymph nodes were palpated for size, consistency, and possible 
sensitivity to pain. By slightly compressing the first tracheal ring manually, it was 
tested whether a cough was induceable. Both jugular veins were investigated for 
integrity and venous pulse. The trachea and lungs were auscultated for abnormal 
respiratory noises. The respiratory rate was counted by closely watching the 
thorax and the abdomen for motions associated with breathing (8-16 breaths per 
minute were considered normal). The heart was carefully examined by 
auscultation, and the heart frequency was noted (28-40 bpm was considered 
normal). The intensity of the heart sound was evaluated as well as the regularity 
of the heartbeat, the distinction between the first and second heart tones, and 
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any heart murmurs. Peristalsis was evaluated by listening to gut movement in the 
quadrants. The posture and weight bearing of all four limbs were checked. The 
pulses were also palpated digitally. The body temperature was measured rectally 
using a digital thermometer (Thermometer-Microlife VT 1831, Lehnecke, 
Schortens/Germany). A temperature between 37.0 °C and 38.0 °C was 
considered normal. Temperatures above 38.5 °C were defined as fever. In foals 
up to an age of three months, temperatures up to 38.5 °C were considered 
normal and temperatures above 39.0 °C were defined as fever. In mares, the 
vulva was checked for abnormal swellings and/or discharge; in stallions, the 
testicles were examined for complete descent, signs of inflammation, and hernia. 
In both stallions and geldings, the prepuce was investigated for signs of 
inflammation such as swelling. 
3.2.4.2 Pre- and post-operative check-ups 
The horses were evaluated immediately before and again on the evening after 
surgery. Behaviour and posture were examined, and the heart rate, respiratory 
rate, and rectal temperature were determined. The oral mucous membranes and 
capillary refill time were also checked. On the evening after surgery, the vein into 
which the catheter had been placed was checked for integrity and signs of 
inflammation.  
During the next five days, the horses were examined daily, but the results of the 
general examinations were not included in the statistical analysis. The patients 
were also checked daily for posture, behaviour, and weight bearing. For the first 
three days after surgery, the rectal temperature was measured mornings and 
evenings, and on days four and five, only in the morning.  
3.2.4.3 Bandage change 
Gloves (Vasco® Basic, Braun Vet Care, Tuttlingen/Germany) were worn while 
changing the bandages. The distal limb bandages consisted of a layer of mull 
(Vetrol Mullwatterolle, Farm and Stable KG, Wiehl/Germany) fixed with an elastic 
bandage (Raucolast®, Lohmann-Rauscher, Neuwied/Germany) and then 
covered with a self-adhesive bandage (Prowrap, Farm and Stable KG, 
Wiehl/Germany). If the operated joint was the coffin joint, the bandage was fixed 
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distally by adhesive tape to the hoof (Gewebe Reparaturband silber, engelbert 
strauss GmbH, Biebergemünd/Germany). After tarsus arthroscopies, the 
bandages consisted of a layer of mull and an adhesive bandage (Optiplaste®-C, 
BSN medical GmbH, Hamburg/Germany). A bandage was not applied on 
patients recovering from knee surgery. Instead, the incision sites were covered 
with a Zinc Cover (ESS GmbH, Bakum/Germany). These surgical lesions at the 
knee were looked after daily, but the evaluation sheet was filled in only on the 
first, third, and fifth days after surgery as well as after all other procedures. 
3.2.4.4 Wound evaluation 
For evaluating the wounds, a semi-quantitative scoring system was developed by 
the author, which was applied during the bandage changes on the first, third, and 
fifth day after surgery. Before starting this clinical part of the study, the scoring 
system was tested on patients that had undergone orthopaedic surgery. If a 
patient had more than one surgical lesion, the highest score determined was 
entered into the evaluation sheet. The appearance of the wound was judged for 
wound exudation (Table 1), swelling and pain (Table 2), skin temperature (Table 
3), and suture dehiscence (Table 4).  
Exudation (Table 1) was scored according to its character. The amount of 
exudate was not considered because it was only present in the amount absorbed 
by the bandage material and according to experience, only in minimal to slight 
amounts. Non-purulent exudate was scored with 1 point. Purulent exudate was 
considered severe and was therefore scored with 3 points. For this parameter, a 
score of 2 points did not exist. 
A swelling (Table 2) was scored with 1 point if the area operated on was only 
slightly thicker than it had been before surgery and was not painful by touch to 
the horse. The swelling was scored with 3 points if the distension of the tissue 
was drastic, the sutures were notching the swollen tissue, and touching the area 
was painful. The back of one’s gloved (Vasco® Basic, Braun Vet Care, 
Tuttlingen/Germany) hand was used to evaluate the temperature of the skin 
(Table 3). One score point was considered when the skin felt slightly warmer 
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than the surrounding area. The increase in skin temperature was considered 
severe (3 points) when the skin felt hot.  
The surgical wounds were closed in a simple interrupted pattern. Minimally 
invasive procedures required 1-2 sutures per incision. For other interventions, the 
number of sutures depended on the length of the surgical incision. Usually, 5-7 
sutures were placed. Dehiscence was scored with 3 points when more than half 
of the sutures were out of place (Table 4). For non-minimally invasive 
interventions where less than 50% of the sutures were dehiscent, a score of 1 
point was given when there were only 1-2 sutures dehiscent, and a score of 2 
points if more than 2 sutures were involved.  
For calculating the total score, the score points for exudation, swelling and skin 
temperature were added up. Dehiscence was not included in the total score, as 
clinical improvement was not possible in this parameter. A statistical analysis 
used the score points of each parameter as well as the sum of the score values. 
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Table 1: Evaluation of exudation  
Character of the exudate  Clinical score 
Dry and clean 0 
Serous 1 
Serosanguinous 1 
Purulent 3 
Haemopurulent 3 
 
Table 2: Evaluation of swelling and pain 
Extent of swelling and pain Clinical score 
No swelling 0 
Low-grade swelling, not painful 1 
Middle-grade swelling, mildly painful 2 
High-grade swelling, severely painful 3 
 
Table 3: Evaluation of skin temperature 
Extent of calor Clinical score 
Normal skin temperature 0 
Mild increase 1 
Moderate increase 2 
Severe increase 3 
 
Table 4: Evaluation of dehiscence 
Severity of dehiscence Clinical score 
No sutures dehiscent 0 
1-2 sutures dehiscent 1 
≤ 50% of sutures dehiscent  
when more than 2 sutures were applied  2 
> 50% of sutures dehiscent 3 
 
  
31 
An evaluation sheet which was placed in front of the patient’s stable had to be 
filled in by the author after every bandage change and wound evaluation. After 
the author’s internship at Tierklinik Lüsche GmbH, the wounds of 15 horses were 
examined by two colleagues who were very well acquainted with the scoring 
system. Together with the author, they evaluated the surgical wounds of at least 
five of the horses before evaluating the wounds on their own.  
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3.2.5 Laboratory studies 
3.2.5.1 Blood collection and preanalytic procedures 
Blood for the laboratory tests was obtained by puncturing the jugular vein on the 
day prior to surgery as well as on day one, three, and five after surgery. A gauze 
swab (ES Kompressen unsteril 5x5 cm 8fach 100 ST PZN 01447157, Paul 
Hartmann AG, Heidenheim/Germany) was moistened with alcohol (kodan® 
Tinktur forte farblos, Schülke & Mayr GmbH, Norderstedt/Germany), and the 
puncture site of the jugular vein was disinfected. A 20G needle (Terumo® Agani 
Needle 20G x 1½" Yellow, Terumo Deutschland GmbH, Eschborn, Germany) 
was placed into the vein at a 45° angle. A syringe (BD DISCARDIT™ II, BD, 
Heidelberg/Germany) was then attached and blood was aspirated. If the patient 
had thrombosed jugular veins, the blood was taken from the sinus venae 
transversae faciei. After disinfecting it, a 20G needle was inserted perpendicular 
to the head directly under the facial crest, and a vacuum was created.  
Directly after recovering from the surgery (before plasma transfusion), blood was 
obtained through the intravenous catheter. Of the blood obtained, the first 20 ml 
were discarded. The blood thus collected was directly transferred into tubes 
(VACUETTE® Röhrchen, Greiner Bio-One GmbH, Frickenhausen/Germany). 
After collecting each blood sample, the blood was filled into a Lithium-Heparin 
tube and a serum tube (Z Serum Sep Gerinnungsaktivator, VACUETTE® 
Röhrchen, Greiner Bio-One GmbH, Frickenhausen/Germany). An EDTA tube 
(K3E K3EDTA, VACUETTE® Röhrchen, Greiner Bio-One GmbH, 
Frickenhausen/Germany) was collected on the day prior to surgery as well as on 
day 5.  
The blood was processed within two hours. EDTA tubes were inverted several 
times in order to achieve an equal cell distribution throughout the sample before 
blood was transferred into the LaserCyte® tubes or the VACUETTE® tubes were 
inserted into the ProCyte®. To separate the blood cells from the plasma, the 
Lithium-Heparin tubes were centrifuged for 5 minutes at 865 g (EBA 20, Andreas 
Hettich GmbH & Co. KG, Tuttlingen/Germany). The heparin plasma was used for 
measuring the creatinine. The serum containers were centrifuged for 10 minutes 
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at 865 g. The serum was decanted into multi-purpose tubes (Röhre 13ml, 
95x16.8mm, PS, Sarstedt, Nümbrecht/Germany) and stored at -18°C. The blood 
samples of horses operated in Sanakena were similarly centrifuged. The heparin 
plasma and serum were decanted into multi-purpose tubes (Röhre 13ml, 
95x16.8mm, PS, Sarstedt, Nümbrecht, Germany), frozen at -18°C and 
transported frozen to Lüsche on the next day. The EDTA samples were stored at 
4°C and transported cooled to Lüsche on the day after collection, too. The 
laboratory investigations (CBC, creatinine) were performed immediately after 
delivery. In order to prove that there were no valid differences between 
haematology values of the same sample directly after having been obtained and 
after having been refrigerated for 24 hours, a storage experiment of five blood 
samples was performed. WBCs were performed directly after blood collection 
and after being refrigerated for one day. A correlation factor of 0.99 was found. 
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3.2.5.2 Laboratory parameters 
To monitor the patients’ health before and after elective surgery, a number of 
laboratory tests were performed (Table 5). For reference intervals, the ranges 
specified by the respective laboratory or manufacturer were applied and are 
listed together with the respective results. 
Table 5: Laboratory investigations 
 Day 
 -1 0 1 3 5 
Haematology1 X    X 
Creatinine1 X  X X X 
SAA2 X X X X X 
Iron2 X X X X X 
Haptoglobin2 X X X X X 
Albumin2 X X X X X 
Globulin2 X X X X X 
Total Serum Protein2 X X X X X 
1: Tierklinik Lüsche GmbH 
2: Central Laboratory, Department of Veterinary Medicine, 
 Justus-Liebig University, Gießen 
 
Haematology was performed on the day prior to surgery and on the fifth day after 
surgery. For the first 46 probands, the LaserCyte® Dx Hematology Analyzer 
(IDEXX Europe B.V., Hoofddorp/The Netherlands) was used. After these 46 
horses, the ProCyte Dx® Hematology Analyzer (IDEXX Europe B.V., 
Hoofddorp/The Netherlands) was utilised due to a laboratory machine change in 
the clinic. The LaserCyte® Dx Hematology Analyzer works with laser flow 
cytometry (Idexx 2015). The ProCyte Dx® Hematology Analyzer also is based on 
laser flow cytometry, but additionally utilises optical fluorescence and laminar 
flow impedance™ (Idexx 2015). The equality of both analysers was tested by 
comparing CBCs in sixteen blood samples from different horses. A correlation 
factor for WBC of 0.99 was found.  
To monitor the health of the horses’ kidneys, the creatinine was measured every 
second day (starting one day prior to surgery) until the fifth day after surgery. The 
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creatinine was determined with the Catalyst Dx® Chemistry Analyzer (IDEXX 
Europe B.V., Hoofddorp/The Netherlands). Spectral analysis is the functional 
principle of the Catalyst Dx® Chemistry Analyzer for determining the 
concentrations of blood parameters (Idexx 2015). 
The serum amyloid A, iron, haptoglobin, albumin, globulin, and total serum 
protein were measured at the central laboratory of the department of veterinary 
medicine of the Justus-Liebig-University, Gießen. The samples were transported 
frozen to the laboratory where they were stored at -18°C until analysed in 
batches. The automated analyser utilized was a Pentra 400 ABX (HORIBA ABX 
SAS, Montpellier Cedex 4/France). The SAA was determined using the latex 
agglutination assay “Eiken” serum amyloid A (Mast House, Bootle, 
Merseyside/United Kingdom) where SAA-antibodies bonded with latex react with 
the SAA possibly present in the sample. The SAA-concentration is determined by 
measuring the change in turbidity (Mast House 2015). For haptoglobin, the 
PHASE™ RANGE Haptoglobin kit (Second Generation; Tridelta Development 
Limited, Maynooth/Ireland) was used. This measurement is based on the 
preservation of the peroxidase activity of haptoglobin-haemoglobin complexes at 
a low pH, as the peroxidase activity of haemoglobin alone is inhibited under 
acidic conditions (Tridelta Development Limited 2015). The method used for 
determining the iron was the ABX Pentra Iron CP (HORIBA ABX SAS, 
Montpellier Cedex 4, France) was colourimetry. Under acidic conditions, the iron 
is separated from the transferrin. This is followed by a redox reaction with iron 
and ascorbic acid (reduction from Fe3+ to Fe2+), then blue iron (II) – ferene 
complexes form and are quantitatively detected (Horiba 2015). Colourimetry is 
also the basic principle in the albumin measurement by the ABX Pentra Albumin 
CP kit (HORIBA ABX SAS, Montpellier Cedex 4, France). At pH 4.2, bromocresol 
green binds selectively to albumin, and a blue colouration results (Horiba 2010). 
The biuret test is used for determining the total serum protein (LT Sys® Labor + 
Technik, Eberhard Lehmann, Berlin, Germany). Bivalent copper and protein form 
purple complexes under alkaline conditions. The colour intensity is directly 
proportional to the protein concentration (Hallbach 2006). The concentration of 
globulins is determined by subtracting the albumin concentration from the total 
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serum protein concentration. All measurements were performed in accordance 
with their manuals by experienced laboratory personnel.  
3.2.6 Statistical analysis of the prospective study 
The statistical assessment of the data was supported by Dr. Klaus Failing and 
Marion Sparenberg from the Unit for Biomathematics and Data Processing, 
Justus-Liebig University, Gießen/Germany.  
The the data of the two independent groups – horses that underwent clean 
orthopaedic surgery and received antibiotics as a single shot (treated) versus 
horses that had no antimicrobial drugs administered (control) – were compared 
statistically. The main target parameters were the score points assorted to the 
surgical incisions. 
Most of the statistical tests (ANOVA, Wald test, t-test, chi-square test, Wilcoxon-
Mann-Whitney test) were conducted using BMDP/Dynamic, Release 8.1 (Dixon 
1993) (Statistical Solutions Ltd., Cork/Ireland). For Fisher’s exact test and the 
exact Wilcoxon-Mann-Whitney test, StatXact-9 (9.0.0, Cytel, Cambridge, 
Massachusetts/USA) (Cytel 2010) was additionally used. Data are presented as 
arithmetic mean ± standard deviation (minimum – maximum), if not mentioned 
otherwise and the significance level was set at 0.05 as usual.  
Data were tested for normal distribution. If data were skewed (Serum Amyloid A, 
age), they were logarithmized before analysis and and delogarithmized for 
presentation. For these data, instead of comparison the arithmetic means and 
standard deviation, the geometric means and dispersion factors were used 
instead.  
Treated and control group tested for equality before the intervention. Groups 
were tested for differences in age (Wilcoxon-Mann-Whitney test), weight (t-test), 
and gender (Fisher’s exact test).  
Also, the groups were tested for differences regarding surgery-related factors: for 
the main target parameters, namely the score points applied to the wounds, the 
exact Wilcoxon-Mann-Whitney test was used.  
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For the secondary objective parameters, Fisher’s exact test, the t-test, and the 
Wilcoxon-Mann-Whitney test were performed. 
The t-test was performed to detect differences in rectal body temperatures 
between the groups at the single measurements per day. Also, the t-test was 
used to determine the differences between the groups regarding WBC, creatinine, 
iron, haptoglobin, albumin, globulin, and total protein as well as rectal body 
temperatures. To test for differences in the SAA-concentrations, the Wilcoxon-
Mann-Whitney test was performed.  
Fisher’s exact test was used to detect any differences regarding the type of 
surgery and the number of legs/joints operated on, the various analgesic drugs 
used, and the surgeon. The t-test was applied for testing for differences in 
duration of the surgery. The chi-square test was used for testing for differences in 
seasons and the Wilcoxon-Mann-Whitney test was used for testing for 
differences in hospitalisation time. 
Additionally, a multifactorial ANOVA was performed to consider the common 
effect of the influencing variables daytime and/or day of measurement on clinical 
scores, laboratory parameters, and body temperatures. Since not all data sets 
were complete, the Wald test (method of maximum likelihood) was used for the 
laboratory parameters. 
For the graphical presentation of the data, Microsoft® Excel® for Mac 2011 
(Version 14.5.2) was used.  
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4 Results 
4.1 Retrospective study 
4.1.1 Study population 
Of the 684 case files retrieved, 32 horses (4.7%) were not included in the 
statistical evaluation. Reasons for not considering these case files were a 
development of respiratory disease post-surgically (13), incomplete 
documentation (8), intra-operative euthanasia (4), surgical treatment of other 
diseases that required induction of antimicrobial therapy (4), development of 
severe gastrointestinal disease (2), and one horse in whose file arthroscopy was 
scheduled but was actually presented for a septic joint. In total, the case files of 
652 horses contained complete documentation. For 560 (85.9%) of these, 
information on the breed was given: 524 were Warmbloods (93.6%), and only 36 
patients belonged to other breeds. These included Quarter Horses (11), ponies 
(9), Friesians (3), Arabian horses (2), Icelandic horses (2), Pura Raza Española 
(1) as well as Haflinger (1), Norwegian Fjord horse (1), Trotter (1), Welsh (1), 
Thoroughbred (1), and Lipizzaner (1). Furthermore, one Arab-Icelandic cross and 
one Arab-pony cross were included in the study. 
The gender was noted in 616/652 (94.5%) of horses included. The study 
population consisted of 154 stallions, 251 geldings, and 211 mares (Table 6). 
The frequency of applying the antibiotics significantly varied between the sexes 
(p = 0,0001): 54.5% of the stallions received antibiotics whereas only 34.1% of 
the mares and 36.3% of the geldings received perioperative antimicrobial 
treatment. 
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Table 6: Distribution of gender (known for 616/652) 
 
PAP Control Total 
n % n % n % 
Geldings 91 36.8 160 43.4 251 40.7 
Mares 72 29.1 139 37.7 211 34.2 
Stallions 84 34.0 70 19.0 154 25.0 
Total 247 100 369 100 616 100 
PAP: perioperative antimicrobial prophylaxis 
The horses’ age, for which the details were available on 615/652 (94.3%) horses, 
ranged from 43 days (0.12 years) to twenty years. The horses that received 
prophylactic antimicrobials were significantly younger (5.0 ± 3.9 years) than the 
controls (7.1 ± 4.3 years; p < 0.0001). The body weight was recorded for 73/652 
(11.2%) horses, which means that 579 horses were not weighed prior to surgery, 
but their body weight was estimated by experienced clinicians. Treated horses 
(593 ± 95 kg) were significantly heavier than the controls (532 ± 133 kg; p=0.03).  
A white blood cell count (WBC) was performed in 302/652 (46.3%) cases prior to 
surgery. The average WBC was 7.90 ± 2.34 G/l (range: 2.90 – 16.65 G/l). The 
WBC in treated horses (8.57 ± 2.58 G/l; n=135) was significantly higher (p < 
0.0001) than in controls (7.37 ± 1.98 G/l; n=167). Among the different kinds of 
surgery, the WBC was distributed significantly different (p=0.012). However, this 
was attributed mainly to the comparatively rare desmotomies and splint bone 
extractions in which surgeons preferred to administer antibiotics if they showed 
relatively high WBCs. In a total of only six combinations of surgical procedures, 
antibiotics were administered to cases with low WBC (Table 7).  
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Table 7: Kind of surgical intervention and respective WBC (mean; G/l) 
Kind of surgery 
PAP (n=135) Control (n=167) Total 
n WBC n WBC n 
Arthroscopy 107   8.62 109 7.58 216 
Fasciotomy     3   7.43   12 6.52   15 
Splint bone extraction   11   9.04   12 7.31   23 
Tenonotomy     6 10.71   12 7.40   18 
Tendovaginoscopy/Bursoscopy     2   6.18     7 7.06     9 
Neurectomy     3   7.43   12 6.47   15 
Combination     3   4.67     3 7.50     6 
PAP: perioperative antimicrobial prophylaxis 
Furthermore, in the multivariate analysis of just the patients in which a 
preoperative WBC was evaluated, a significant interaction was detected between 
the perioperative antimicrobial prophylaxis and the number of surgical lesions. 
However, overall the WBC was not significantly different between patients with 1, 
2, or ≥3 surgical lesions. 
4.1.2 Perioperative antimicrobial prophylaxis 
4.1.2.1 Antibiotic agents 
Of the 652 patients included, 259 (39.7%) received perioperative antibiotic 
prophylaxis (PAP), whereas 393 (60.3%) horses did not (controls). 171 horses 
received penicillin-based antibiotics, and 36 were given trimethoprim and 
sulfadiazine. Combinations of gentamicin and penicillin-based antibiotics was 
administered in 43 cases. Seven horses were treated with cephalosporins. Other 
combinations (cefquinome and gentamicin; trimethoprim-sulfadiazine and 
gentamicin) were used in two patients undergoing arthroscopy (Table 8). For the 
statistical analysis, gentamicin and penicillin-based antibiotic were grouped 
together with cephalosporins since a quite similar broad spectrum efficacy was 
assumed. The antibiotic administration started in the evening prior to surgery and 
continued for 3-5 days. Each antibiotic agent was dosed as appropriate to its 
pharmacokinetics. The antibiotic substances varied according to the preference 
of the surgeon and over time. 
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Table 8: Antibiotic agents used in the retrospective study 
  Pen-b TMS Pen-b + Genta Other 
 n % n % n % n % 
Arthroscopy  130 76.0 28 77.8 37 74.0 2 100 
Fasciotomy 6 3.5 0 0.0 2 4.0 0 0.0 
Splint bone extraction  12 7.0 2 5.6 5 10.0 0 0.0 
Tenotomy 12 7.0 2 5.6 2 4.0 0 0.0 
Neurectomy 6 3.5 2 5.6 0 0.0 0 0.0 
Tendovaginoscopy/ 
Bursoscopy  2 1.2 1 2.8 0 0.0 0 0.0 
Combinations  3 1.8 1 2.8 4 8.0 0 0.0 
Total 171 100 36 100 50 100 2 0.0 
Pen-b: Penicillin-based antibiotics: Procaine-benzylpenicillin, procaine– 
            benzylpenicillin plus dihydrostreptomycin, and amoxicillin; 
TMS: Trimethoprim-Sulfadiazin;  
Pen-b+Genta: Penicillin-based antibiotics and gentamicin 
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4.1.2.2 Types of surgery 
The application of antibiotics significantly varied between the types of surgery 
(p=0.0007). The majority of the patients underwent arthroscopy (462/652). 
Fourteen patients had two different procedures done during one surgical session. 
Perioperative antimicrobial prophylaxis was most often initiated in combinations 
of different surgeries (57.1%) and least often administered in 
tendovaginoscopy/bursoscopy (Table 9).  
Table 9: Types of surgery and administration of perioperative antimicrobial 
prophylaxis (PAP) in absolute numbers and percentages  
 
PAP 
(n=259) 
Control 
(n=393) 
Total 
(n=652) 
n % n % n % 
Arthroscopy 197 42.6 265 57.4 462 100 
Fasciotomy  8 18.6 35 81.4 43 100 
Splint bone 
extraction  19 46.3 22 53.7 41 100 
Tenotomy  16 43.2 21 56.8 37 100 
Neurectomy 8 25.0 24 75.0 32 100 
Tendovaginoscopy/
Bursoscopy 3 13.0 20 87.0 23 100 
Combinations  8 57.1 6 42.9 14 100 
Total  259 39.7 393 60.3 652 100 
 
4.1.2.3 Number of surgical lesions 
The more surgical lesions were placed in one surgical session, the more often 
perioperative antimicrobial prophylaxis was initiated (p= 0.03). In 479 horses, one 
joint/leg was operated, and in 180 (37.6%) of these patients, perioperative 
antibiotics were prescribed. Thirty horses had three or more surgical 
interventions in one session, and two-thirds of them were operated under 
antibiotic cover (66.7 %; Table 10). 
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Table 10: Perioperative antimicrobial prophylaxis (PAP) and number of surgical 
lesions 
 
PAP 
(n=259) 
Control 
(n=393) 
Total 
(n=652) 
n % n % n % 
1 surgical 
lesion 180 37.6 299 62.4 479 100 
2 surgical 
lesions 59 41.3 84 58.7 143 100 
≥ 3 surgical 
lesions 20 66.7 10 33.3 30 100 
Total 259 39.7 393 60.3 652 100 
 
4.1.2.4 Surgeons 
629 out of the 652 surgeries were performed by four surgeons (297, 136, 109, 
and 87 each). Twenty horses were operated on by four other surgeons. For three 
interventions, the surgeon could not be identified. The frequency of antibiotic 
prophylaxis significantly depended on the surgeon (p<0.0001). Three colleagues 
used antibiotics in 28.6% to 39.0% of their cases (n=520) whereas the fourth 
surgeon and the group “other surgeons” administered antibiotics to 65.0% and 
73.4% of their patients (n=129, Table 11). 
Table 11: Performing surgeon and application of perioperative antimicrobial 
prophylaxis (PAP; known for 649/652) 
 PAP 
(n=259) 
Control 
(n=393) 
Total 
(n=649) 
n % n % n % 
Surgeon A  85 28.6 212 71.4 297 100 
Surgeon B  28 32.2 59 67.8 87 100 
Surgeon C  53 39.0 83 61.0 136 100 
Surgeon D 80 73.4 29 26.6 109 100 
Other  13 65.0 7 35.0 20 100 
Total 259 39.9 390 60.1 649 100 
 
44 
During the evaluation period, 42 veterinarians assisted the responsible surgeon. 
Six of them participated in more than 30 surgeries. For 51 procedures, the 
assisting surgeon could not be determined. Due to the high number of assisting 
veterinary surgeons and the even higher number of combinations with the 
responsible surgeons, an influence of the assisting veterinary surgeon was not 
assumed, and therefore, a further statistical analysis not pursued. 
4.1.2.5 Year and season 
The rate of antibiotic application varied significantly between years (p <0.0001) 
and seasons (p = 0.03) of surgery. The annual distribution of the surgeries and 
the administration of perioperative prophylactic antibiotics during the period 
reviewed is shown in Table 12. Except for 2011, where the study started in the 
middle of the year, and 2015, which just included January, the number of 
surgeries ranged from 170 to 196 per year. Regarding the three full years of the 
study, the fewest horses were operated under antimicrobial cover in 2012.  
Table 12: Annual distribution of surgeries and application of perioperative 
antimicrobial prophylaxis (PAP) 
 
PAP 
(n=259) 
Control 
(n=393) 
n % n % 
June to Dec. 2011 44 43.6 57 56.4 
2012 50 27.5 132 72.5 
2013 102 52.0 94 58.0 
2014 61 35.9 109 64.1 
Jan. 2015 2 66.7 1 33.3 
Total 259 39.7 393 60.3 
Table 12 shows the seasonal distribution of surgeries and the application of 
perioperative antimicrobial prophylaxis. The number of surgeries performed in 
the different seasons was almost equal. The fewest horses (150/652) were 
operated on in spring, and the most horses during winter (180/652). 
Perioperative antimicrobial prophylaxis was significantly applied differently 
between the seasons (p = 0.03). In winter and spring, percentage-wise more 
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horses were operated on with antimicrobial prophylaxis than in summer and 
autumn. 
Table 13: Seasonal distribution of surgeries and application of perioperative 
antimicrobial prophylaxis (PAP) 
 
PAP (n=259) Control (n=393) 
n % n % 
Dec.-Feb. 79 43.9 101  56.1 
March-May 70 46.7 80  53.1 
June-August 52 32.5 108  67.5 
Sept.-Nov. 58 35.8 104  64.2 
Total  259 39.7 393  60.3 
 
4.1.3 Complications 
Of the 652 surgical candidates, a total of 255 (39.1%) developed some kind of 
complications, whereas the healing was completely inconspicuous in 397 (60.9%) 
of the patients (Table 13). Overall, there was no significant difference in the 
development of post-surgical complications between the treated and the control 
horses (p=0.5). Entirely uncomplicated healing was observed in 162/259 (62.6%) 
antibiotic-receiving horses and in 235/393 (59.8%) controls. On the other hand, 
97/259 (37.5%) horses that received antimicrobial prophylaxis and 158/393 
(40.2%) controls developed complications during the healing process (Table 14). 
Table 14: Development of complications and distribution of perioperative 
antimicrobial prophylaxis (PAP) in 255/652 patients in absolute 
numbers and percentages 
 PAP 
(n=259) 
Control 
(n=393) 
n % n % 
Complication  97 37.5 158 40.2 
Inconspicuous  162 52.5 235 59.8 
Total 259 100 393 100 
Looking into the kinds of complications in more detail, there were no significant 
differences between PAP and control horses as well. 
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4.1.3.1 Arthritis  
The worst and potentially life-threatening complication, septic arthritis, occurred 
in 7/463 (1.51%) patients that underwent arthroscopy. One horse underwent 
arthroscopy and fasciotomy and was therefore classified into the “combination of 
surgical procedures” group. It developed septic arthritis 27 days after the 
procedure despite receiving perioperative penicillin. Looking at the patients that 
underwent only arthroscopy, the incidence in the controls was 2/265 (0.76%) and 
4/197 (2.03%) in the group with perioperative antibiotics. This difference was not 
statistically significant (p = 0.12). 
A total of 5 horses developing septic arthritis despite perioperative antibiotic 
administration received either penicillin (2), trimethoprim and sulfadiazine (2), or 
penicillin and gentamicin (1), starting on the day before surgery and ending five 
days after surgery. Septic arthritis occurred postoperatively on days  2 (3 horses), 
3, 5, 6, and 27 respectively. One of the controls with septic arthritis was 
euthanized 9 days after surgery. More details on the outcome of horses with 
septic arthritis can be found in section 4.1.3.4 “Course and Outcome”. 
4.1.3.2 Alterations at the incision site  
Moderate and severe wound swelling was observed in 167/652 of the cases 
(25.6%). It was present in 99/393 controls (25.2%) and in 68/259 antibiotic-
receiving horses (26.3%). Exudation was found in 75 patients. In 49 cases, this 
was the only postoperative complication. 34/49 (69.4%) did not receive 
antimicrobial prophylaxis, and 15 (30.6%) did. Purulent exudation was present in 
12 patients (11 controls, 1 treated). Five controls with purulent discharge also 
developed suture dehiscence, three showed increased swelling too and one 
control concurrently developed a seroma (Table 15). Details on course and 
outcome can be found in section 4.1.3.5 “Course and outcome”. 
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Table 15: Complications after elective orthopedic surgery in equines with or 
without perioperative antimicrobial prophylaxis (PAP) 
 
PAP 
(n=259) 
Control 
(n=393) 
Total 
(n=652) 
n % n % n % 
Dehiscence 4  1.5 8 2.0 12 1.8 
Seroma 3  1.2 2  0.5 5  0.8 
Exudation without incisional 
alterations  15  5.8 34  34.6 49  7.5 
Exudation with  
incisional alterations 8  3.1 18  4.6 26  4.0 
Moderate or  
severe Swelling  68  26.3 99  25.2 167  25.6 
Fever without  
incisional alterations 2  0.8 13  3.3 15 2.3 
Fever with  
incisional alterations 3  1.2 12  3.1 15  2.3 
Individuals with at least one 
complication 97  37.5 158  40.2 255  39.1 
 
4.1.3.3 Postsurgical fever 
Postsurgical fever (≥ 38.6°C) occurred in 30/652 (4.60%) of the patients. Five of 
the 259 horses in the PAP group (1.93%) and 25/368 controls (6.79%) developed 
abnormally high body temperature. Statistically, there was no significant 
difference between the groups (p=0.2). 
In 15 horses, fever was the only complication: 2/15 (13.3%) received 
perioperative antibiotics, and 13/15 (86.7%) controls developed just the high 
body temperature. Fourteen feverish horses showed an alteration at the incision 
site, too; two of these (14.3%) had been treated with antibiotics whereas the 
other 12/14 (85.7%) belonged to the control group.  
One patient that received trimethoprim-sulfadiazine developed a fever and signs 
of septic arthritis on day six after surgery. One colt treated with penicillin 
developed a fever, seroma at the incision site, and self-limiting diarrhoea.  
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4.1.3.4 Time of occurrence 
In the controls, complications occurred significantly earlier (3.5 ± 2.9 days; range 
1-14 days) than in the antibiotic-receiving patients (4.9 ± 4.4 days; range 1-27 
days; p=0.01).  
Of all the 255 complications, 195 (76.5%) developed prior to the fifth day after 
surgery. Of these horses, 67 (34.3%) had been treated antibiotically, and 128 
(65.6%) had not (p = 0.13). The interactions between the complications arising 
until day five and the antimicrobial prophylaxis varied according to season  
(p = 0.005).  
The onset of two joint infections, one seroma/neuroma, seven cases of 
dehiscence, and nine cases of exudation occurred later than five days after 
surgery. The remaining 41 post-surgical complications setting in more than five 
days after surgeries were cases of increased swelling (Figure 2).  
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Figure 2: Onset of postsurgical complications in 255 treated and control horses 
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4.1.3.5 Course and outcome  
As soon as a septic joint was diagnosed, which occurred in a total of seven 
patients that underwent arthroscopy (1.51%), systemic antibiotics, multiple joint 
lavages including the instilling of antibiotics, and intravenous regional limb 
perfusion were initiated. Horses with increased swelling were monitored carefully 
for other signs of surgical site infection. Alterations other than increased swelling 
were treated locally, and systemic antimicrobial therapy was initiated if necessary. 
In 14/25 control horses that developed fever, antimicrobial therapy was initiated. 
Of these 14 horses, eight did not show any alteration at the incision site.  
Regarding the outcome, overall, no significant differences were found between 
the horses receiving antibiotics and the controls (p=0.3). Of all patients, 606/652 
(92.9%) were discharged. Twenty-one antibiotically treated patients, as well as 
21 controls, were operated on for at least a second time because more 
orthopaedic interventions were necessary. Two horses that were still unsuitable 
for riding remained in the clinic. Their hospitalization time was not included in the 
statistical analysis. One horse in the treatment group (penicillin) with no incisional 
alterations was humanely destroyed due to a severe lameness remaining despite 
prolonged treatment. One horse in the control group was euthanized due to 
complications in its septic joint after nine days. The other six horses were 
discharged. Information about a return to athletic performance was not available 
(Table 16). 
Table 16: Outcome 
 
PAP 
(n=259) 
Control 
(n=393) 
Total 
(n=652) 
n % n % n % 
Discharge 236 91.1 370 94.1 606 92.9 
2nd surgery 21 8.1 21 5.3 42 6.4 
Euthanasia 1 0.4 1 0.3 2 0.3 
Stayed 1 0.4 1 0.3 2 0.3 
Total 259 39.7 393 60.3 652 100 
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The median hospitalisation time for horses with antimicrobial prophylaxis was 11 
days (range 2-179 days) and for controls 10 days (range 1-185 days, Table 17). 
The PAP horses nearly stayed significantly longer in the clinic than the control 
horses (p=0.055). The hospitalisation time was significantly affected by the 
surgeon (p=0.01) as well as by the type of surgery (p=0.001). The horses 
remaining at the clinic for a long time stayed either for rehabilitation under the 
supervision of a veterinary orthopaedic surgeon or due to a prolonged treatment 
of severe complications such as septic arthritis. 
Table 17: Hospitalization time (known for 606/652) 
 PAP 
(n=259) 
Control 
(n=393) 
Minimum (days) 2 1 
1st quartile (days) 10 9 
Median (days) 11 10 
3rd quartile (days) 16 14 
Maximum (days) 179 185 
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4.2 Prospective clinical study 
4.2.1 Study population 
4.2.1.1 Drop-outs 
In total, 75 horses needed to be included in the randomized study in order to 
arrive at the aspired group size of 30 patients each. Sixteen patients (21.3%) 
dropped out due to one of the following reasons (Table 18):  
Six horses were discharged after surgery without being hospitalized for five days. 
Five of these did not receive antibiotics. 
Four horses were not examined exactly as scheduled. During their hospitalization, 
the emergency load at the clinic was so high that it was decided to change the 
bandages of these patients every third day instead of every second, as long as 
the patients were otherwise sound, and their vital parameters were within normal 
limits. Two of these patients received preoperative antibiotics, the other two did 
not. All wounds were inconspicuous, and the horses went home sound. 
The antibiotic protocol of three horses was changed by the responsible surgeon. 
All three were randomized into the antibiotic receiving group. In two cases, the 
surgeon decided to administer additional gentamicin on the first two days after 
surgery. In the other case, additional antimicrobials were listed on the invoice but 
not in the patient file. Due to this discrepancy, it was decided to drop this patient 
from the study.  
Three more horses were randomised without including their data in the statistical 
analysis: In Horse 42, the necessity of implants became evident intra-operatively. 
Horse 1 underwent a second surgery on day 4. This horse had OCD lesions in 
multiple joints, so that not all of them could be removed in one surgical session. 
Horse 33 developed a severe respiratory infection.  
In total, nine drop-outs were randomised as controls whereas seven received 
preoperative antibiotics. Thirteen of the 16 drop-outs underwent arthroscopy, and 
tendovaginoscopy, fasciotomy, and fasciotomy/neurectomy were performed on 
one patient each.  
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Table 18: Characterization of drop-outs (n = 16) 
Reason for 
drop-out 
Patient 
Number 
AB Breed Age Gender Type 
of Surgery 
Early 
discharge 
5 No  WB 2 G Arthroscopy 
6 No WB 2 G Arthroscopy 
9 No  WB  2 S Arthroscopy 
17 Yes WB 2 G Arthroscopy 
22 No A 13 M Arthroscopy 
35 No  WB 4 G Arthroscopy 
Change of 
examination 
protocol 
46 No WB 11 G Arthroscopy 
47 Yes WB 6 G Fasciotomy 
48 Yes WB 2 S Arthroscopy 
49 No  Trotter 6 S Arthroscopy 
Change of 
antibiotic 
protocol 
36 Yes Pony 8 G Tendovaginoscopy 
39 Yes WB 5 M Arthroscopy 
40 Yes  WB  15 G Fasciotomy/ 
neurectomy 
Implant  42 Yes WB 11 G Arthroscopy 
2nd surgery 1 No  WB 2 G Arthroscopy 
Respiratory 
disease  
33 No WB 2 S Arthroscopy 
WB: Warmblood; A: Arabian; S: Stallion; G: Gelding; M: Mare; AB: Antibiotics 
4.2.1.2 Characteristics of the study population 
A total study population of 60 horses was planned with a group size of 30 
patients each. However, Horse 36 completed the observation period but was 
excluded due to an inconsistency in its patient file. Therefore, 59 horses in total 
remained for statistical evaluation. Twenty-eight horses received preoperative 
antimicrobials, and 31 served as controls without antibiotic treatment. One horse 
did not receive antimicrobials due to a communication error, but stayed in the 
study as a control, because all its examinations took place as planned.  
Fifty warmbloods, 3 ponies, 2 Arabian horses, 2 Quarter Horses, 1 Frisian as well 
as 1 Icelandic horse finished the study (Table 19). Of the 59 horses, eleven were 
stallions, 31 geldings, and 17 mares. Six stallions, 16 geldings, and 6 mares 
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received prophylactic antimicrobial treatment. The genders were distributed 
evenly between the groups (p = 0.57). 
The horses’ average age was 5.3 ± 2.3 years. It ranged from four months to 23 
years. The average age of horses with antimicrobial prophylaxis was 5.3 ± 2.8 
years (0.3 – 23 years); the control group was aged 5.3 ± 1.9 years (2 – 16 years). 
The age was not significantly different between the groups (p = 0.97). 
The horses weighed 534 ± 91.9 kg (190 – 698 kg). The treated horses weighed 
525.6 ± 109.7 kg (range: 190 – 698 kg) and controls 541.7 ± 73.2 kg (range: 400 
- 670 kg). There was no significant difference between the groups (p = 0.5). 
Table 19: Patient data in treated and control group (no significant differences) 
 Treated (n = 28) Control (n = 31) Total (n = 59) 
Stallions 6 5 11 
Geldings 16 15 31 
Mares 6 11 17 
Age (years) 5.3 ± 2.8 5.3 ± 1.9 5.3 ± 2.3 
Weight (kg) 525.6 ± 109.7 541.7 ± 73.2 534 ± 91.9 
 
Hospitalization time, too, was not significantly different between the groups 
(p = 0.27, Table 20). The horses in the control group stayed hospitalized for a 
median (min – max) of 11 days (6 – 43 days) and the treated horses for a median 
of 10 days (5 – 77 days). 
Table 20: Comparison of hospitalization duration (days) between groups (no 
significant difference) 
 Treated (n = 28) Control (n = 31) Total (n = 59) 
Minimum 5.0 6.0 5.0 
1st quartile 8.0 10.0 8.5 
Median 10.0 11.0 10.0 
3rd quartile 13.0 12.0 12.5 
Maximum 77.0 43.0 77.0 
 
As a non-steroidal anti-inflammatory drug (NSAID), 44 horses received 
phenylbutazone and 15 horses meloxicam (Table 21). The groups differed 
significantly (p = 0.03) as to the choice of NSAID: The patients in the treated 
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group received meloxicam more often than the patients in the control group – 
which implies that phenylbutazone was used more often in the controls. 
In three horses, phenylbutazone was discontinued on the day after surgery due 
to elevated creatinine levels (52: treated, 53: control) or anorexia (64: treated). 
After discontinuing the phenylbutazone, the three horses stayed weight-bearing 
and lame-free. The creatinine levels returned to normal limits. Horse 64 resumed 
to feeding normally. There were no elevated creatinine levels or anorectic horses 
noted in the 15 horses that received meloxicam. 
Table 21: NSAID application according to group (p = 0.03)  
 Treated 
(n=28) 
Control 
(n=31) 
Total 
(n=59) 
Phenylbutazone 17 (38.6%) 27 (61.4%) 44 
Meloxicam 11 (73.3%) 4 (26.7%) 15 
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4.2.2 Surgical procedures 
Thirty-six (61%) of the 59 study participants underwent arthroscopy (Table 22). 
Of these, 19 were not treated with antimicrobials, whereas 17 received the 
amoxicillin-gentamicin combination once preoperatively. 
Table 22: Joints (n=47) and patients (n=36) undergoing arthroscopy according to 
group 
 Treated Control Total 
1 fetlock joint 8 6 14 
1 tarsal joint 2 4 6 
2 fetlock joints 2 3 5 
1 stifle 2 2 4 
1 coffin joint 1 2 3 
2 tarsal joints 1 0 1 
1 fetlock and  
1 coffin joint 0 1 1 
2 fetlock joints and 
1 tarsal joint 1 0 1 
1 fetlock joint and 
2 tarsal joints 0 1 1 
Total horses 17 19 36 
Total joints 22 25 47 
The second most frequently performed surgeries were tendovaginoscopy, 
tenotomy, or their combination, which were summarized in one group for 
statistical evaluation (n=9). The types of surgeries were distributed evenly 
between the groups (p=0.5; Table 23). One horse underwent a 
tendovaginoscopy, tenotomy, and a splint bone extraction on the same leg. As 
the tendovaginoscopy/tenotomy took longer than the splint bone extraction, the 
horse was assigned to the tendovaginoscopy/tenotomy group. Nine horses 
underwent tendovaginoscopy, tenotomy, or combinations of these, and 5 of them 
received preoperative antimicrobial prophylaxis. One distal splint bone was 
extracted in 8 horses of which two were treated with antibiotics. Fasciotomy, 
neurectomy, and the combination of these surgeries were summarised in one 
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group for statistical evaluation because in the hind limbs, these surgeries were 
generally performed simultaneously.  
Table 23: Types of surgeries (not significantly different between groups) 
 Treated 
(n=28) 
Control 
(n=31) 
Total 
(n=59) 
Arthroscopy 17 (47.2%) 19 (52.8%) 36 (61.0%) 
Tendovaginoscopy/Tenotomy 5 (55.6%) 4 (44.4%) 9 (15.3%) 
Splint Bone Extraction 2 (25.0%) 6 (75.0%) 8 (13.6%) 
Neurectomy/Fasciotomy 4 (66.7%) 2 (33.3%) 6 (10.2%) 
Total 28 (47.5%) 31 (52.5%) 59 (100%) 
Forty-six horses had one surgical intervention, and 22 of these received 
antibiotics. Eleven horses underwent two surgical interventions in their surgery 
session, and 5 of these were treated with antibiotics. Two horses (1 treated, 1 
control) had three arthroscopies during their one surgery session. For statistical 
evaluation, horses with more than one surgical lesion were grouped together. 
Horses with one and patients with two or more surgical lesions were distributed 
evenly between the treatment and control groups (p = 0.6). In patients with more 
than one surgical intervention, the highest score reached in the evaluation of all 
wounds was filled in the evaluation sheet.  
Five different surgeons performed the surgical interventions. Two of them only 
had one surgery, and one of them six, so that these three surgeons were 
summarised in the group “other”. There was no significant difference in the 
distribution of antimicrobial prophylaxis between the surgeons (p = 0.47, Table 
24). 
Table 24: Surgical interventions per surgeon (treated/control) 
 Surgeon A Surgeon B Other 
Arthroscopy  20 (9/11) 10 (4/6) 6 (4/2) 
Tendovaginoscopy/Tenotomy 3 (1/2) 6 (4/2) 0 
Splint bone extraction  4 (2/2) 3 (0/3) 1 (0/1) 
Neurectomy/Fasciotomy  3 (1/2) 2 (2/0) 1 (1/0) 
Total  30 (13/17) 21 (10/11) 8 (5/3) 
58 
 
The 16 assisting veterinarians were not considered in the statistical evaluation 
because an assisting surgeon mostly just passed the surgical instruments to the 
surgeon in charge and did not manipulate the wound himself.  
Surgery time ranged from 24 to 115 minutes with an average of 57 ± 21 minutes. 
Horses without antimicrobial prophylaxis were operated on for 55 ± 19 minutes 
with a range of 25 - 105 minutes. The intervention in horses with antimicrobial 
prophylaxis lasted for 60 ± 23 minutes (24 - 115 minutes). A significant difference 
between the groups in the duration of the surgery was not detected (p = 0.42).  
All horses recovered to a standing position between 30 – 60 minutes after the 
end of their procedure. The recovery time was not subjected to statistical 
analysis. 
4.2.3 Clinical examinations 
According to the results of the pre-anaesthetic examinations, all horses were 
clinically healthy from an internal medical point of view and only showed their 
orthopaedic problem. The horses had a body temperature of 37.5 ± 0.41 °C (36.5
- 38.4°C). The arithmetic means and standard deviations of the temperatures 
measured during the study are displayed in Table 25. In 10 patients, it was not 
possible to take the temperature on all occasions because they were 
uncooperative and/or behaving dangerously. In four controls a temperature 
measurement was not possible at all. In six horses (4 control, 2 treated), only 41 
out of 66 measurements could be taken. 
In the initial examination, three horses showed slightly elevated body 
temperatures (38.2 °C, 38.4 °C, 38.6 °C). This rise in body temperature was 
probably induced by the transport to the clinic. The temperatures of these horses 
were within normal limits at the next measurement. Temperatures below 37.0°C 
were observed 20 times in 11 patients during winter (Table 25). 
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Table 25: Temperatures (°C) during the study given as arithmetic mean ± 
standard deviation (Minimum - Maximum) 
 Treated Control 
Day T n T n 
-1 evening 37.60 ± 0.44 (36.5 – 38.4) 26 
37.45 ± 0.36 
(36.5 - 38.0) 28 
0 morning 37.49 ± 0.49 (36.0 – 38.7) 25 
37.53 ± 0.39 
(36.6 - 38.0) 28 
0 evening 37.80 ± 0.44 (37.0 – 38.6) 26 
37.94 ± 0.68 
(37.0 - 40.2) 28 
1 morning 37.59 ± 0.45 (36.7 – 38.5) 24 
37.51 ± 0.33 
(36.8 – 38.1) 26 
1 evening 37.51 ± 0.49 (36.7 – 38.5) 25 
37.57 ± 0.28 
(37.0 - 37.9) 27 
2 morning 37.50 ± 0.41 
(36.7 – 38.5) 
26 37.77 ± 0.59 (37.0 – 39.7) 27 
2 evening 37.45 ± 0.39 (36.5 – 38.3) 25 
37.66 ± 0.52 
(37.0 – 39.5) 27 
3 morning 37.47 ± 0.44 (36.1 – 38.3) 26 
37.72 ± 0.51 
(36.5 – 38.9) 27 
3 evening 37.35 ± 0.45 (36.2 – 38.3) 25 
37.54 ± 0.36 
(36.7 – 38.2) 27 
4 morning 37.45 ± 0.39 (36.1 – 38.0) 26 
37.46 ± 0.28 
(36.9 – 38.0) 28 
5 morning 37.44 ± 0.33 
(36.9 – 38.1) 
25 37.59 ± 0.56 (36.9 – 39.6) 28 
Bold: Temperature > 38.5 °C 
Five horses (1 treated, 4 controls) showed elevated body temperatures within 5 
days postoperatively (Figure 9). The course of rectal body temperatures and 
specific treatment of the horses is explained in detail in section 4.2.7 
“Inflammatory parameters in horses with post-surgical fever”. 
The courses of morning temperatures from day 0 to day 5 of all horses were 
analysed statistically using a two-factorial Wald test. Statistically significant 
differences could neither be determined between the groups, nor between the 
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days of measurement, nor for their interactions. A three-factorial Wald test was 
performed for the days with two temperature measurements (days 0 to 3). The 
considered factors were antibiotic treatment, day, and daytime of measurement. 
No significant differences between the groups were found. However, a 
statistically significant difference for the different days of measurement (p = 0.02) 
was detected as well as a significant influence of the interactions of day and 
daytime (p <0.0001). The temperatures were furthermore analysed within each 
day with two measurements (day 0 to day 3). The analysed factors were 
antimicrobial prophylaxis and daytime of temperature determination. No 
significant differences were detected between the groups. On the day of surgery, 
body temperatures were significantly higher in the evening (p < 0.0001) than in 
the morning. On the third day after surgery, temperatures were significantly 
higher in the morning than in the evening (p = 0.007). Regarding the single 
temperature measurements on the day before and on the days 4 and 5 after 
surgery, no significant difference between the groups was determined.  
In the evening after surgery, 3 control horses were detected with an elevated 
heart rate (Horse 3: 48 bpm; Horse 34: 72 bpm; Horse 56: 52 bpm). Two of these 
horses concurrently showed a slightly elevated body temperature (Horse 3: 
38.4°C; Horse 56: 38.2 °C), whereas Horse 34 had a fever of 39.1°C. Since 
Horse 56 showed a very nervous behaviour during the examination, this was 
deemed to be the cause for the slightly elevated clinical parameters.  
Horse 64 (treated) was anorectic on the day after surgery. The horse received 
phenylbutazone, and after discontinuing the NSAID, it restarted feeding normally.  
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4.2.4 Wound evaluations 
Using a two-factorial ANOVA, globally significant differences were detected 
between the groups in total score, swelling, and skin temperature (Table 26) 
whereas exudation and dehiscence were neither different between the groups 
nor between days. 
Table 26: Results of two-factorial ANOVA in wound evaluation scores 
 Difference 
between groups 
Difference 
between days 
Interaction between 
AB and day 
Total score 0.002 <0.0001 n.s. 
Exudation  n.s.  n.s.  n.s. 
Swelling  0.002 <0.0001 n.s. 
Skin temperature  0.007 0.0002 n.s.  
Dehiscence n.s.  n.s.  n.s.  
AB: 10 mg/kg amoxicillin and 6.6 mg/kg gentamicin once preoperatively  
n.s.: not significant 
4.2.4.1 Total score 
During the five-day evaluation period, the total scores were significantly higher in 
the treated group than in the control group (p = 0.002). The total score decreased 
significantly over time (p < 0.0001). Also, in a post-hoc analysis (Wilcoxon-Mann-
Whitney Test), the total score was significantly higher in horses with antimicrobial 
prophylaxis at the evaluations on day (p = 0.03) and 5 (p = 0.01). On day 3, the 
difference between the groups was almost significant (p = 0.06,Table 27).  
Table 27: Total scores in treated in control horses  
 Treated Control p 
Day 1 2.23 ± 1.18 1.48 ± 1.12 0.03 
Day 3 1.89 ± 1.29 1.24 ± 0.89 0.06 
Day 5 1.46 ± 1.25 0.71 ± 0.85 0.01 
 
However, in both groups, most horses only had an absolute total score of 3 
points or less (Figure 3 - Figure 8). The highest scores were observed in the 
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treated group on day one. Three horses had 7.5, 5, and 4 score points each 
(Figure 7). On the other hand, ten horses, of which eight were in the control 
group, had a total score of 0 points on the first day after surgery. Six horses in 
each group showed a total score of 0 points on day three. On day five, six horses 
in the treated and 15 horses in the control group received 0 points.  
On day three after surgery, the highest score of 4 points was reached by three 
antimicrobial-treated patients as well as by one control. Four points were also 
given to two horses in the treated group on day five.  
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Figure 3: Individual wound scores in controls on day 1 
 
 
Figure 4: Individual wound scores in controls on day 3 
 
 
Figure 5: Individual wound scores in controls on day 5 
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Figure 6: Individual wound scores in treated horses on day 1 
 
 
Figure 7: Individual wound scores in treated horses on day 3 
 
 
Figure 8: Individual wound scores in treated horses on day 5 
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4.2.4.2 Exudation 
Regarding exudation, no significant differences were found, either between 
groups or between days. At each evaluation, more than 75% of all patients did 
not have any exudation from their incisions. Purulent wound discharge (3 score 
points) was only observed in one horse (horse 61) in the treated group on day 5. 
This patient underwent neurectomy. Like in the previous evaluations, the wound 
additionally showed a low-grade swelling (1 score point), no increase in skin 
temperature (0 score points), and no dehiscence. The patient responded well to 
local treatment. After developing the exudation, the wound was cleaned daily and 
disinfected with octenidine (Octenisept®, Schülke and Mayr GmbH, 
Norderstedt/Germany). After cleaning, an antibiotic ointment was applied. The 
score points for exudation are shown graphically in section 4.2.4.1 “Total Score” 
in Figures 4-9. 
4.2.4.3 Post-surgical swelling 
During the first five days after surgery, the horses receiving antibiotics showed 
significantly more swelling at the incision site than horses in the control group  
(p = 0.002). The swelling decreased significantly during the observation period  
(p < 0.0001). Horses in the treated group had significantly higher swelling scores 
on the first (p = 0.02) and fifth (p = 0.002) day after surgery than the controls had. 
However, there was no significant difference between groups on the third day  
(p = 0.1).  
On the first day after surgery, the surgical wounds in eleven horses did not show 
any swelling at all (treated: 2; control: 9). On day one, the swelling around the 
incision in most horses (treated: 14; control: 16) was scored with one point. The 
highest score given on this day was 2 score points, which was attributed to 6 
horses in the treated and to 2 horses in the control group. Only one treated 
patient developed a swelling scored with three points on the fifth day after 
surgery. Additional complications did not occur in this horse. 
4.2.4.4 Skin temperature 
During the study period, the antibiotic-receiving horses had statistically significant 
higher skin temperatures around their incisions than the horses in the control 
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group (p = 0.007). The skin temperature differed significantly over time (p = 
0.0002). Regarding each time point individually, the skin temperature around the 
incisions was significantly higher in horses that had received perioperative 
antimicrobials on the days 1 (p = 0.04) and 3 (p = 0.03) after surgery.  
To the incisions in the control group, 0 or just 1 point was given during the study 
period. Four horses in the treated group received 2 points on day one due to their 
skin temperature around the incision. On days 3 and 5, it was one treated horse 
that received 2 points on each day.  
4.2.4.5 Dehiscence 
Dehiscence developed in just three of the 59 patients (2 treated, 1 control). On 
the first day after surgery, dehiscence was already present in two horses (horse 
21 and horse 64) in the treated group. In Horse 21, none of the 2 sutures that 
should cover an arthroscopy portal wound were in place any more. A fractured 
splint bone was extracted in horse 64. Two sutures out of seven were dehiscent 
at the first wound evaluation. On day five, 1 control patient (horse 16) was given 
1 point for dehiscence. In this patient, who had a splint bone removed, the lowest 
two sutures of the incision became dehiscent. All three patients responded to 
local treatment and were discharged in sound condition.  
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4.2.5 Laboratory parameters 
During the course of the study, each of the 59 patients should have had his blood 
parameters checked 5 times (n=295). However, the following samples were 
lacking: In one control horse, haematology and creatinine were not performed on 
the day before surgery. Its leucocytes were counted manually (6.5 G/l) but due to 
the different method, not included in the statistical analysis. The creatinine value 
was not determined on this day, too, due to a problem in the laboratory. In four 
more horses (3 controls, 1 treated), the inflammatory parameters and creatinine 
values were not determined on the day prior to surgery due to a communication 
problem. On the fifth day after surgery, the leucocytes in one control were 
determined manually (8.3 G/l) and, therefore, not considered for statistical 
evaluation. As some of the serum samples were haemolytic, 4 iron 
concentrations could not be included in the statistical evaluation (see page 73). 
Overall, for statistical purposes, the number of samples per parameter were 
deemed satisfactory. Due to the values sporadically lacking for statistical analysis, 
Wald tests were performed. 
No statistically significant differences were detected in the inflammatory 
parameters between the groups, whereas mostly highly significant differences 
were calculated between the different days they were determined. Significant 
interactions of prophylactic antibiotic treatment and day of measurement were 
found for SAA. For iron, this difference was just not statistically significant (Table 
28).  
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Table 28: Laboratory parameters – results of the two-factorial Wald-test 
 Influence of AB Influence of day 
Interaction between 
AB and day 
SAA 
(n=291) n.s. <0.0001 <0.0001 
Iron 
(n=287) n.s. <0.0001 0.06 
Haptoglobin 
(n=291) n.s. <0.0001 n.s. 
WBC 
(n=116) n.s. 0.01 n.s. 
Albumin 
(n=291) n.s. <0.0001 n.s. 
Globulin 
(n=291) n.s. <0.0001 n.s. 
Total Protein 
(n=291) n.s. <0.0001 n.s. 
Creatinine* 
(n=231) n.s. <0.0001 n.s. 
AB: Amoxicillin and gentamicin once pre-operatively; n.s.: Not significant  
*: Creatinine was checked 4 times (day prior to surgery, day 1, day 3, day 5) 
 
 
4.2.5.1 Serum amyloid A (SAA) 
The SAA values of four patients (3 controls; 1 treated) were not available prior to 
surgery. The cut-off value for healthy horses is an SAA concentration of less than 
2.7 µg/ml. Eight patients (6 treated, 2 controls) showed elevated SAA 
concentrations prior to surgery. A more than 100-fold elevation was present in 3 
horses (54, 29, and 64, Table 29).  
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Table 29: Patients with elevated SAA (µg/ml) prior to surgery 
Patient AB Day -1 Day 0 Day 1 Day 3 Day 5 
54 No 1351.1 933.4 1086.3 411.8 133.2 
29 No 953.5 1009.1 1132.5 2372.4 2187.8 
64 Yes 802.5 740.8 499.5 289.7 17.6 
28 Yes 40.3 0.7 6.3 0.3 1.1 
14 Yes 29.5 2.5 651.3 440.3 36.7 
50 Yes 21.4 48.3 498.8 307.8 9.5 
59 Yes 11.8 51.5 277.2 32.5 0.1 
61 Yes 3.4 4.0 297.5 209.4 0.1 
AB: 10 mg/kg amoxicillin and 6.6 mg/kg gentamicin once preoperatively.  
Cut off: <2.7 µg/ml. Bold: Values above cut-off.  
 
Horse 54 (control) showed its highest SAA (1351.1 µg/ml) on the day prior to 
surgery. The cause for this elevation could not be determined. The horse was 
randomised into the control group, and its SAA, directly after surgery on day 0, 
dropped to 933.4 µg/ml. The surgery (a splint bone extraction) only slightly 
elevated SAA in this horse to 1086.3 µg/ml on day 1, and the follow-up 
measurements on days 3 and 5 showed a dramatic normalisation. The post-
surgical healing process in Horse 54 was completely inconspicuous with a total 
score of 0 points at every wound evaluation. 
Horse 29 (control) which underwent arthroscopy and which had the second-
highest pre-operative SAA of 953.5 µg/ml, was castrated a few days prior to the 
orthopaedic intervention. The SAA concentrations continued to rise in this horse 
until the third day after surgery (2372,4 µg//ml). Horse 29 received 1 score point 
each at the wound evaluations on day 1 and 3 after surgery for swelling and 
incisional skin temperature. On day 5, the incision was given 0.5 points for 
swelling and 1 point for incisional skin temperature, respectively. No other 
abnormalities were noted during the observation period. This horse was 
discharged 13 days after surgery without any complications. 
In Horse 64 (treated), the initial SAA concentration (802.5 µg/ml) steadily 
declined despite the surgical intervention (splint bone extraction) to a less than 
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tenfold elevation on day five. However, this horse developed a surgical site 
infection with suture dehiscence. It received phenylbutazone and temporarily 
developed elevated creatinine levels. More details concerning its healing process 
can be found in chapter 4.2.6 “Inflammatory parameters of horses with surgical 
site infections”. 
Using the Wald test, no global significant difference in SAA levels was detected  
(p = 0.18) between the groups. There was a significant difference in the SAA 
concentrations between the days of sample collection (p < 0.0001). Also, a 
significant interaction was calculated between the day of sample collection and 
the antibiotic treatment (p < 0.0001). Analysing each day separately with the 
Wilcoxon-Mann-Whitney test, the SAA levels were significantly higher in the 
controls than in the treated group (Table 30) on the third (p = 0.03) and fifth (p = 
0.007) day after surgery.  
Equine patients in both groups already showed an increase in median SAA 
concentrations on the first day after surgery. In the controls, the highest median 
concentration was reached on day 3 (239.1 µg/ml, Table 30). A lower median 
with 19.2 µg/ml was seen on day 5, but the value was still higher than before the 
surgical intervention (0.2 µg/ml). In the treated group, the highest median was 
observed on day 1 after surgery with 155.8 µg/ml. The median was close to its 
initial value (0.5 µg/ml) on day 5 after surgery (Table 30). 
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Table 30: SAA (µg/ml) in treated and control patients before and after surgery.  
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n.s.: not significant. 
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On day five after surgery, the highest SAA level in treated horses was 159,2 
µg/ml. Four control horses, of which just one developed a surgical site infection, 
had severely elevated SAA concentrations (>1500 µg/ml) on day 5 (Table 31). 
Except horse 30, that developed septic arthritis on day 8, all horses showed 
inconspicuous healing with a total score of 0 points.  
 
Table 31: Control horses (4/31) with elevated SAA (µg/ml) concentration on day 
5 after surgery 
Horse SAA -1 SAA 0  SAA 1  SAA 3 SAA 5 
3 0.1 1.2 12.6 2079.1 4692.0 
29 953.5 1009.1 1132.5 2372.4 2187.8 
30 1.0 0.2 480.3 525.9 1565.6 
63 1.0 1.0 363.5 2031.0 1968.2 
Cut off <2.7 µg/ml. Bold: Values above Cut off. 
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4.2.5.2 Iron  
Forty-three of the 291 samples were macroscopically haemolytic. Of these, 27 
(63%) were collected directly after surgery. Five were taken on each, the first and 
fifth day after surgery. Four were obtained on the day prior to surgery, and two on 
the third day after surgery.  
Iron values in haemolytic samples were not included in the statistical evaluation if 
they were more than twice as high than the value measured directly before or 
after. This happened in 4 samples: directly after surgery in Horses 29 (control) 
and 64 (treated); on day 3 in Horse 30 (control), and on day 5 in Horse 16 
(control).  
In three patients (1 treated, 2 controls), initial iron concentrations were not within 
the reference interval (14.0 - 43.0 µmol/l, Table 32).  
Table 32: Serum iron (µmol/l) concentrations outside the reference interval prior 
to surgery in patients undergoing elective surgery on day 0 
Patient AB Day -1 Day 0 Day 1 Day 3 Day 5 
30 No 65.6 56.5* 14.4 67.4 7.7 
29 No 9.0 48.9* 16.2 10.4 17.9 
59 Yes 7.7 9.4 7.0 25.7 28.6 
AB: 10 mg/kg amoxicillin and 6.6 mg/kg gentamicin once preoperatively;  
*: Value not considered for statistical evaluation due to haemolytic sample. 
Reference interval: 14.0 - 43.0 µmol/l. Bold: Values not within normal limits. 
 
Horse 29, which was castrated a few days prior to the orthopaedic intervention 
and also showed elevated SAA levels prior to surgery, had iron levels below the 
reference interval on the day prior to surgery as well as on day 3. It received 1 
score point for swelling and incisional skin temperature at the wound evaluations 
on day 1 and 3 after surgery. On day 5, the incision was given 0.5 points for 
swelling and 1 point for incisional skin temperature, respectively.  
Horse 59 (arthroscopy) showed serum iron concentration below the reference 
interval prior to surgery as well as on day 0 and 1. On day 3 and 5, its iron values 
were within the reference interval. This horse received 2 score points for swelling 
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on days 1 and 3. On day three, the swelling had increased to 3 score points. The 
incisional skin temperature decreased from 1 score point on days 1 and 3 to 0 
points on day 5.  
The serum iron concentrations in Horse 30 (arthroscopy) showed the biggest 
abnormalities: they were above the reference interval prior to surgery as well as 
on day 0 and 3. On day 5, the serum iron concentration was below the reference 
interval. On the 8th day after surgery, Horse 30 developed a septic arthritis of the 
coffin joint operated on. The disease process is described in detail in chapter 
4.2.6 “Inflammatory parameters in horses with surgical site infections”. 
Regarding all patients, no statistically significant differences in iron 
concentrations were found between the groups (p=0.76), but between the 
different days of sample collection (p<0.0001). The iron concentrations on day 1 
were notably lower than at other points in time (Table 33). 
Table 33: Serum iron concentrations (µmol/l) in treated and control patients 
before and after surgery 
 Treated Control 
Day concentration n concentration n 
-1 24.3 ± 6.8 (7.7 - 37.7) 27 
26.4 ± 10.1 
(9.0 - 65.6) 28 
0 25.1 ± 6.1 (9.4 - 43.2) 27 
28.3 ± 8.4 
(15.3 - 56.5) 30 
1 14.2 ± 6.7 (5.7 – 37.0) 28 
13.0 ± 6.5 
(4.2- 35.8) 31 
3 26.0 ± 5.6 (9.8 - 33.1) 28 
23.6 ± 11.9 
(4.9 - 68.2) 30 
5 25.5 ± 9.8 (7.9 - 57.1) 28 
21.7 ± 8.6 
(7.7 - 42.1) 30 
Mean ± standard deviation (minimum-maximum). Reference interval 14.0-43.0 
µmol/l. Bold: Iron concentrations outside the reference interval. 
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4.2.5.3 Haptoglobin 
Initial haptoglobin concentrations were elevated in 14 patients (Table 34). Four of 
them received preoperative antimicrobial treatment, and 10 did not.  
Table 34: Patients with elevated haptoglobin concentrations prior to surgery 
Patient AB Day -1 Day 0 Day 1 Day 3 Day 5 
19 Yes 4.04 1.92 1.82 1.64 1.31 
28 Yes 4.50 0.93 1.54 1.71 3.85 
32 No 3.86 4.16 4.22 5.71 6.37 
41 No 2.68 1.94 1.80 2.46 2.84 
43 No 3.18 2.96 3.02 4.20 4.08 
44 No 4.38 3.72 2.70 7.62 8.32 
50 Yes 3.04 3.24 3.36 3.46 3.06 
54 No 4.32 3.60 4.54 4.56 4.90 
55 No 3.16 2.88 2.52 2.86 2.54 
56 No 3.24 3.20 3.16 3.44 3.82 
58 No 2.50 2.18 3.06 3.40 3.04 
59 Yes 2.82 3.42 3.04 4.72 4.78 
60 No 2.68 2.48 2.10 2.20 2.20 
63 No 2.60 2.60 1.29 1.81 1.73 
AB: 10 mg/kg amoxicillin and 6.6 mg/kg gentamicin once preoperatively. 
Reference interval: 0.13-2.47 mg/ml. Bold: Values above upper limits. 
In Horse 59, the initial SAA and iron concentrations were also not within the 
reference interval. In Horses 28, 50, and 54, the initial iron concentrations were 
not within normal limits as well.  
In Horse 43, a serous exudation scored with 1 point developed on day five after 
surgery. In Horse 59, a swelling scored with 3 points developed on the fifth day 
after surgery.  
In all other horses with initially elevated haptoglobin levels, the total wound score 
decreased continuously during the observation period.  
There were no significant differences between the groups regarding haptoglobin 
concentration (p=0.85). However, as in SAA and iron, the haptoglobin 
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concentration was significantly different between the days of sample collection  
(p < 0.0001, Table 35). Haptoglobin concentrations showed a continuous 
increase throughout the study period. On day 3, an elevation of the mean 
haptoglobin concentration above the reference interval was observed, which 
increased even further to day 5.  
Table 35: Haptoglobin (mg/ml) in treated and control patients before and after 
surgery 
Day Control (n = 31) Treated (n = 28) 
-1 2.27 ± 1.05 
(0.83 – 4.38) 
2.18 ± 0.90 
(0.66 – 4.5) 
0 2.19 ± 1.02 
(0.67 – 4.16) 
2.14 ± 0.99 
(0.48 – 4.23) 
1 2.20 ± 1.02 
(0.89 – 4.54) 
2.35 ± 1.0 
(0.96 – 4.74) 
3 2.89 ± 1.41 
(1.24 – 7.62) 
2.78 ± 1.31 
(1.34 – 6.79) 
5 3.05 ± 1.68 
(1.04 – 8.32) 
2.87 ± 1.25 
(1.14 – 6.12) 
Data presented as the mean ± standard deviation (minimum-maximum). 
Reference interval 0.13-2.47 mg/ml. Bold: Values above upper limits  
4.2.5.4 Albumin, globulin, and total protein 
For albumin, globulin, as well as total protein, no significant differences between 
the groups were found. The Wald test revealed a significant difference between 
the days of the sample collection for the concentrations of the protein fractions 
(Albumin: p < 0.0001; globulin: p < 0.0001, total protein: p < 0.0001). 
It is obvious (Table 36) that the concentrations of the protein fractions did not 
differ much during the sampling period. A slight decline in the concentrations of 
both, albumin, and globulin and therefore also in the total serum protein was 
seen directly after surgery (day 0). All concentrations returned to the range of the 
initial levels already on the day after surgery. 
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Table 36: Albumin, globulin and total protein in treated and control patients 
before and after surgery  
 Day Control Treated 
Albumin (g/l) 
(27.4-35.7 g/l) 
 
-1 32.7 ± 1.6 (29.7 – 34.9) 
32.0 ± 3.0 
(26 – 37.9) 
0 29.3 ± 2.2 (25.3 – 33.5) 
28.2 ± 2.7 
(20.6 – 31.9) 
1 33.3 ± 1.9 (30.2 – 38.0) 
33.0 ± 3.4 
(22.6 – 37.1) 
3 32.0 ± 2.1 (28.7 – 38.0) 
31.1 ± 2.7 
(24.0 – 37.1) 
5 31.7 ± 1.7 (28.6 – 35.9) 
30.8 ± 2.9 
(24.5 – 36.8) 
Globulin (g/l) 
(24.7-41.5 g/l) 
-1 29.3 ± 4.9 (16.5 – 40.7) 
30.3 ± 3.7 
(22.6 – 37.7) 
0 26.9 ± 3.8 (19.1 – 34.2) 
26.3 ± 4.15 
(18.4 – 33.6) 
1 30.2 ± 3.9 (23.4 – 39.8) 
30.9 ± 4.5 
(23.1 – 38.3) 
3 29.7 ± 3.5 (22.9 – 37.0) 
29.5 ± 3.9 
(22.5 – 36.6) 
5 29.6 ± 3.6 (24.0 – 38.8) 
29.2 ± 3.3 
(22.2 – 38.3) 
Total Protein (g/l) 
(57.7-72.9 g/l) 
-1 61.9 ± 5.0 (50 – 73.1) 
62.4 ± 4.8 
(48.6 – 69.9) 
0 56.2 ± 4.5 (47.0 – 63.5) 
54.5 ± 5.4 
(41.1 – 63.1) 
1 63.5 ± 3.9 (55.4 – 72.0) 
63.9 ± 6.4 
(46.9 – 74.9) 
3 61.7 ± 3.5 (55.1 – 68.8) 
60.7 ± 4.9 
(48.9 – 68.1) 
5 61.3 ± 3.2 (54.7 – 68.0) 
60.1 ± 4.4 
(48.0 – 68.2) 
Data presented as mean ± standard deviation (minimum-maximum). 
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4.2.5.5 White blood cells 
116 samples of 118 planned ones were available for statistical analysis. In one 
control horse prior to surgery and in a different control horse on the fifth day after 
surgery, the WBC was not included in the statistical evaluation due to a different 
determination method (manual WBC count). A significant difference between 
groups in leucocyte numbers was neither determined prior to surgery nor on day 
5. At the day before surgery, the WBC was significantly higher than on day 5 
(p = 0.01). However, from a clinical perspective, this mean decrease remained in 
an irrelevant dimension (Table 37). Patient 9 which underwent a splint bone 
extraction had a WBC of 2.67 G/l on day 5. This horse never showed any fever 
or other abnormalities, which could explain the leucopoenia. On day 5, 1.5 score 
points were given to swelling and 1 score point to skin temperature around the 
surgical incision.  
Table 37: Blood WBC (G/l) in treated and control horses before and 5 days after 
surgery 
Day Control Treated 
-1 7.59 ± 2.30 7.92 ± 1.99 
5 7.11 ± 2.01 6.64 ± 2.67 
Mean ± standard deviation (minimum-maximum). Reference interval: 4.90 - 
11.10 G/l. Bold: Value not within the reference interval. 
 
 
4.2.5.6 Creatinine  
There was no significant difference in the creatinine concentrations between the 
groups (p = 0.58). However, even in the creatinine, a statistically significant 
difference was calculated between the days of measurements. As listed in Table 
38, on day 1 after surgery, the creatinine values in both groups showed a 
maximum. 
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Table 38: Serum creatinine concentration (µmol/l) in treated and control horses 
before and after surgery 
Day Control (n = 31;  
on day -1 n = 27) 
Treated (n = 28;  
on day -1 n = 27) 
-1 120.1 ± 22.4 
(79.6 - 168.0) 
121.1 ± 24.7 
(79.6 - 168.0) 
1 132.6 ± 26.4 
(88.4 - 203.3) 
137.7 ± 28.0 
(79.6 - 194.5) 
3 123.5 ± 24.0 
(88.4 - 194.5) 
128.8 ± 24.6 
(88.4 - 168.0) 
5 118.1 ± 25.2 
(79.6 - 176.8) 
123.8 ± 28.7 
(70.7 - 194.5) 
Mean ± standard deviation (minimum-maximum). Reference interval: 79.65 – 
177.0 µmol/l. Bold: Value not within the reference interval. Values were 
converted from mg/dl to µmol/l.  
 
A total of three individuals, all receiving phenylbutazone as post-surgical NSAID, 
developed increased creatinine levels. The creatinine concentrations in horse 52 
and 53 exceeded the reference interval (79.65-177.0 µmol/l) at the day after 
surgery. After discontinuation of phenylbutazone, their creatinine levels returned 
to the reference interval within the observation period. Horse 75 showed an 
elevated creatinine level on day 5 after surgery. Its creatinine concentration also 
returned to normal limits within two days. 
Table 39: Patients with elevated creatinine levels after surgery (all received 
phenylbutazone) 
  Creatinine 
Patient AB Day -1 Day 1 Day 3 Day 5 
52 Yes 132.6 194.5 168.0 150.3 
53 No 132.6 194.5 141.4 123.8 
59 Yes 141.4 168.0 159.1 194.5 
AB: 10 mg/kg amoxicillin and 6.6 mg/kg gentamicin once preoperatively. 
Reference interval: 79.65 – 177.0 µmol/l. Bold: Values exceeding the reference 
interval. Values were converted from mg/dl to µmol/l.  
 
80 
4.2.6 Inflammatory parameters in horses with surgical site infections 
Septic joint infection after arthroscopy was observed in two horses. However, in 
both cases, the arthritic signs developed after the study period, on day 8 (control 
Horse 30) and 9 (Horse 39), postoperatively. The latter was randomised into the 
treated group, but it had to be dropped because it received additional gentamicin 
already on the first and second day after surgery due to a personal decision of 
the surgeon.  
During the study period, other surgical site infections (SSI) developed in 4 horses. 
Three of these received praeoperative antibiotics, whereas one did not. The 
surgical site infections (SSI) included dehiscence and purulent drainage (Table 
40). 
Table 40: Characterization of patients with SSI 
Type of SSI  Patient AB Type  of Surgery Day 
Septic Joint 
30 No Arthroscopy 8 
39* Yes Arthroscopy 9 
Dehiscence 
21 Yes Arthroscopy 1 
64 Yes Splint bone extraction 1 
16 No Splint bone extraction 5 
Purulent drainage  61 Yes Neurectomy 5 
Day: Day of SSI occurrence; AB: Amoxicillin gentamicin pre-operatively; M: Mare; 
G: Gelding; *: Horse was excluded from statistical evaluation. 
 
The concentrations of the inflammatory parameters of all six horses developing 
either arthritis or other SSI are displayed in Table 41. The surgical wounds of 
these patients are described in detail afterwards. 
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Table 41: Inflammatory parameters in horses with SSI during the study period 
 Day Control Treated 
16  30  21  39#  61  64  
SAA 
Cut-off <2.7 µg/ml 
-1 0.1 1.0 0.1 * 3.4 802.5 
0 0.1 0.2 0.1 0.1 4.0 740.8 
1 670.0 480.3 254.3 3.5 297.5 499.5 
3 2890.7 525.9 106.4 0.1 209.4 289.7 
5 0.1 1565.6 0.1 0.1 0.1 17.6 
Iron 
RI: 14.0-43.0 µmol/l 
-1 26.0 65.6 37.7 * 25.2 27.2 
0 28.3 56.5 26.5 12.6 * 33.7 
1 5.1 14.4 14.4 9.8 17.9 12.3 
3 16.2 56.5+ 27.9 25.0 26.8 31.3 
5 42.1 7.7 31.0 22.4 23.5 42.3 
Haptoglobin 
RI: 0.13-2.47 mg/ml 
-1 1.26 1.70 1.96 * 2.22 1.90 
0 1.14 1.34 1.85 2.48 2.85 1.42 
1 2.09 1.56 2.07 2.52 1.92 1.38 
3 3.38 1.24 1.46 2.44 2.49 2.06 
5 1.04 1.52 1.32 2.58 2.19 1.98 
WBC 
RI: 4.9- 11.1 G/l. 
-1 8.38 4.73 7.96 6.62 9.95 6.23 
5 7.3 11.88 5.32 6.0 5.99 7.52 
#: Horse dropped out of the study due to additional antibiotics from day 1 on; RI: 
reference interval; +: value was not subjected to statistical analysis; *: Missing 
value. Bold: Values outside the reference interval. Highlighted in grey: Horses 
that developed SSI after the observation period. 
Horse 16: Dehiscence on day 5;  
Horse 21: Dehiscence on day 1;  
Horse 30: Arthritis on day 8;  
Horse 39: Arthritis on day 9;  
Horse 61: Purulent discharge on day 5;  
Horse 64: Dehiscence on day 1. 
Horse 30 (control) showed the first clinical signs of a septic joint eight days after 
arthroscopy of the left front coffin joint; the horse was supposed to stay in the 
clinic until suture removal. During the study observation period of 5 days and 
afterwards, the mare showed no fever. The highest temperature in this mare was 
38.2 °C on day 10 after surgery. No increased swelling, soreness (0 score points), 
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or other abnormalities of the wound were detected. However, her serum samples 
showed a steady augmentation of SAA from day 1 to 5. The highest value 
(1565.6 µg/ml) was measured on day 5 after surgery, the last day of the 
examination protocol. At the same time, the white blood cells were only slightly 
elevated (11.9 G/l, reference interval 4.9-11.1 G/l). The serum iron showed a 
decline throughout the sampling period, which was most obvious on day 5 after 
surgery. On day 3, the sample was macroscopically haemolytic and the iron 
value (56.5 µmol/l) more than 4 times higher than the values in the previous and 
following measurement. Therefore, this value was considered as type one error, 
probably due to poor sample handling and was excluded. Haptoglobin values in 
horse 30 remained in the reference interval at all times. In retrospect, in this 
horse, SAA and iron clearly indicated the development of a serious inflammation 
already on day 5.  
Horse 39 (treated, drop-out) developed a joint infection on day 9 after 
arthroscopy of the right front coffin joint, despite receiving additional gentamicin 
(6.6 mg/kg; Belamox®, bela-pharm, Vechta, Germany) on days 1 and 2. Due to 
the additional antibiotic treatment, this horse was not included in the statistical 
evaluation; since standardised clinical and laboratory evaluations took place all 
the same, the results are presented nonetheless: Body temperatures and wound 
evaluations seemed inconspicuous; however, a relatively late – recognised on 
day 5 for the first time – mild swelling of both the incision and the joint developed 
(swelling and total score: 1 point). In this horse, SAA levels were consistently low 
with a maximum of 3.5 µg/ml in the morning after surgery. Directly after surgery, 
the serum iron value (12.6 µmol/l) was below its reference interval. A further 
decrease was seen on day 1 (9.8 µmol/l). On days 3 and 5, the iron levels were 
within the reference interval. The haptoglobin values varied slightly around 2.5 
mg/ml at all times, which is just very slightly above the upper limit of the 
reference interval of 0.13 - 2.47 mg/ml. In summary, the laboratory parameters 
during the first five days after surgery were not indicative of the joint infection 
developing in this patient. 
In the following, the wounds and inflammatory parameters of horses with less 
severe surgical site infections are described.  
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In Horse 16 (control), two sutures became dehiscent (1 score point) on the fifth 
day after a splint bone extraction. The incision was not swollen, and dry (swelling: 
0 score points, exudation: 0 score points), the skin still adapted, and the 
temperature of the surrounding tissue was not increased (0 score points). In the 
morning of the second day after surgery, the patient developed a fever (38.9 °C) 
which resolved after the routine application of phenylbutazone. Afterwards, the 
horse showed no elevated temperature during its stay in the clinic. On day 3 after 
surgery, this patient showed a maximum SAA of 2890.7 µg/ml. On day 5, the 
dehiscence occurred but the SAA had returned to the base level. Iron was low on 
the day after surgery but returned to the reference interval two days later. Just on 
day three, a 2.7-fold elevation of haptoglobin was observed. 
Horse 21 (treated) showed dehiscence on the day after arthroscopy in one out of 
two of the joints operated on (3 score points). The incision with dehiscent sutures 
also showed a slight serous discharge (1 score point), low- to middle-grade 
swelling (1.5 score points), and a moderate increase in skin temperature (2 score 
points). On the third day after surgery, the incision was dry and the swelling 
subsided (1 score point). The skin temperature was not increased (0 score 
points). Five days after surgery, there was no swelling (0 score points), the 
incision remained dry (0 score points), and the skin temperature was within 
normal limits. Fever was never present. Looking at the inflammatory parameters, 
a relatively mild peak in SAA (254.3 µg/ml) was seen in this horse on the day 
after surgery. On day five, the SAA returned to its basal concentration. The 
serum iron value was never below the reference interval. The serum iron level 
declined on day 1 and approached the base level in the following samples. On 
the third day after surgery, this elevation of iron might have been falsely high, as 
the sample was haemolytic. The haptoglobin level showed an increase after 
surgery, which did not exceed the reference interval. On day 3 and 5, this value 
declined. 
In Horse 61 (treated), which underwent neurectomy on both of its front limbs and 
which received prophylactic antibiotic treatment, a haemopurulent discharge (3 
score points) was observed on day five after surgery. Like at the evaluations 
before, the surgical wound showed a low-grade swelling (1 score point), no 
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increased skin temperature (0 score points), and no dehiscence (0 score points). 
On day 5 when the discharge appeared, the SAA already had returned to the 
reference interval, the serum iron exceeded the initial level, and the haptoglobin 
remained within the reference interval. A decrease in the haptoglobin 
concentration was seen in this individual on the day of and the day after surgery. 
The highest haptoglobin concentration was observed after recovering from 
surgery.  
Horse 64 (treated) had two dehiscent sutures out of 7 (1 score point) at the day 
after a splint bone extraction. The horse was part of the antibiotic-receiving group. 
A serosanguinous discharge (1 score point) and a middle-grade swelling (2 score 
points) were present as well. On the third and fifth day after surgery, the exudate 
was serous (1 score point). By day three, the swelling had declined to a low-
grade swelling (1 score point) which remained throughout the following 
evaluation. The skin temperature at the incision site was mildly elevated at all 
evaluation times (1 score point). The horse’s body temperature never exceeded 
38.5°C. The SAA levels were elevated at all times. With 802.5 µg/ml, the 
presurgical SAA level showed an almost 300-fold increase and was the highest 
measured SAA concentration in this patient. This horse never underwent any 
surgery nor experienced any obvious trauma before starting the study. There 
was no explanation found for its high initial SAA values. However, the SAA 
concentration declined steadily but did not return below the cut off of 2.7 µg/ml by 
the fifth day after surgery. As the serum sample that was obtained directly after 
surgery was haemolytic, the serum iron value was probably falsely high (more 
than twice as high than the following value) and, therefore, not considered for the 
statistics. The serum iron concentration declined to 12.3 µmol/l and returned to 
the reference interval on the third day after surgery (Table 41). The course of 
haptoglobin undulated; the highest value was detected directly after surgery, the 
lowest on the day after surgery. The dehiscent incision responded well to local 
treatment. 
Overall, these less severe surgical site infections did not cause prominent 
changes in inflammatory parameters. 
  
85 
4.2.7 Inflammatory parameters in horses with post-surgical fever 
For this study, fever was defined as a rectal body temperature of 38.6°C or 
higher. Five horses (1 treated, 4 controls) showed such elevated body 
temperatures postoperatively within 5 days (Figure 10). Interestingly, only one of 
these horses developed suture dehiscence on day 5 (Horse 16, Table 40). In the 
evening after surgery, two controls had a fever (Horse 32: 40.2 °C; horse 34: 
39.1 °C). Horse 32 was febrile also in the morning of the third day after surgery 
(38.9 °C). Fever was also present in horse 34 on day 5 (39.6 °C). Its total wound 
score on this day was 0 points. On day six, rectal temperature normalised to 
37.8 °C. The patient was bearing weight well and was discharged. A follow-up 
examination including suture removal was scheduled nine days after surgery at 
his home stable. The patient was clinically sound and the surgical wound looked 
inconspicuous. 
Horse 3 (Control) and Horse 32 (Control) were treated with antibiotics for five 
days due to fever. Horse 3 received trimethoprim-sulfadiazine on day 2 and 
horse 32 penicillin, streptomycin, and gentamicin in the evening after surgery, 
respectively. Horse 32 also received Zylexis® ad us. vet. on the day after surgery 
to stimulate its immune system. Horse 14 (Treated) showed a slightly elevated 
temperature at 38.6°C, which was seen only once in the evening after surgery. 
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Figure 9: Temperatures in febrile patients. 
Blue: Controls 
Red: Treated, 
m: Morning of the day of study,  
e: Evening of the day of study.        
Arrows mark the beginning of antimicrobial therapy for 5 days in horse 
3 and 32. 
In the following, the course of inflammatory parameters (Table 42) in horses with 
fever and their accompanying wound evaluation scores are specified. 
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Table 42: Inflammatory parameters in horses with post-surgical fever 
 Treated Controls 
Horse 14  3# 16 32# 34 
Fever Occurrence* e0 m2 e2 m2 
e0 
m3 
e0 
m5 
Temperature peak (°C) 38.6 39.7 39.5 38.9 
40.2  
38.9 
39.1  
39.6 
 Day  
SAA 
Cut-off 
<2.7 µg/ml 
-1 29.5 0.1 0.1 0.3 0.1 
0 2.5 1.2 0.1 1.2 0.1 
1 651.3 12.6 670.0 1195.0 385.0 
3 440.3 2079.1 2890.7 1601.3 255.9 
5 36.7 4692.0 0.1 399.0 143.5 
Iron 
RI:          
14.0-43.0 µmol/l 
-1 35.5 29.7 26.0 22.0 21.8 
0 24.0 34.1 28.3 24.5 24.4 
1 12.2 18.1 5.1 4.9 6.7 
3 16.9 5.3 16.2 21.9 19.6 
5 23.0 16.0 42.1 19.6 7.7 
Haptoglobin 
RI:         
0.13-2.47 mg/ml 
-1 3.11 1.29 1.26 3.86 1.60 
0 2.69 1.21 1.14 4.16 1.59 
1 2.70 0.89 2.09 4.22 1.92 
3 2.50 2.85 3.38 5.71 4.09 
5 3.28 4.84 1.04 6.37 4.86 
WBC 
RI: 4.9 – 11.1 G/l. 
-1 6.15 5.36 8.38 8.95 6.54 
5 12.35 4.44 7.3 6.41 11.34 
RI: reference interval; Bold: Value exceeding the reference interval * e0: evening 
day 0; e2: evening day 2; m2: morning day 2; m3: morning day 3;  
m5: morning day 5 
#: Initiation of antibiotics 
 
Horse 3 (control) was febrile on both temperature measurements on the second 
day after surgery. On the day after surgery, 1.5 points were given for swelling 
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and 1 point for skin temperature around the incisions. The swelling subsided to 0 
points on the third day after surgery. On day five, 0.5 points were given for 
swelling. The skin temperature around the incisions remained at 1 point. A minor 
increase in SAA, from 1.2 µg/ml to 12.6 µg/ml, was observed on the day after 
surgery. Its concentration massively increased to 2079.1 µg/ml on the third day 
after surgery and further to 4692 µg/ml on day five. The lowest iron value (5.3 
µmol/l) was observed on the third day after surgery. The lowest haptoglobin 
concentration in Horse 3 was measured on the day after surgery (0.89 mg/ml). 
An increase in haptoglobin concentration was observed on day 3 (2.85 mg/ml) 
with a further increase on day 5 (4.84 mg/ml). The WBC decreased from 5.36 G/l 
prior to surgery to 4.44 G/l on day five. This value was just below the reference 
interval. 
In Horse 14 (treated), which was febrile in the evening after surgery, 1.5 points 
were given for swelling on the day after surgery. Also, on day 1, the SAA reached 
its highest concentration (651.3 µg/ml), whereas the iron level showed its lowest 
(12.2 µmol/l). On day 3, the score for swelling was 2 points and on day 5, one 
point was given for swelling. On day 5, the highest haptoglobin concentration 
was measured (3.28 mg/ml). The WBC was approximately twice as high on the 
fifth day after surgery than prior to surgery (12.35 G/l). The skin temperature 
around the incision was consistently scored with one point.  
In the morning of the second day after surgery, the horse 16 (control) developed 
a fever (38.9 °C) which resolved afterwards while receiving the regular 
application of phenylbutazone. Two distal sutures of the initial seven became 
dehiscent (score: 1) on the fifth day after a splint bone extraction. The incision 
was not swollen, and dry, the skin still adapted, and the temperature of the 
surrounding tissue was not increased (total score: 0 points). In this patient, the 
SAA reached its highest concentration on the third day after surgery (2890.7 
µg/ml). On day 5, the dehiscence occurred, SAA had returned to the base level 
(0.1 µg/ml). Iron declined on the day after surgery and returned to the reference 
interval two days later. On day three, a 2.7-fold elevation of haptoglobin was 
observed. 
89 
Horse 32 (control) was febrile in the evening after surgery and in the morning of 
the third day after surgery. For its incision a total score of 0 points was given on 
days 1 and 5. On the third day after surgery, a swelling was present, which was 
scored with 1.5 points. Concurrently with the fever on day 3, the highest SAA 
concentration was measured on the third day after surgery, too (1601.3 µg/ml). 
The lowest iron concentration was measured on day 1 (4.9 µmol/ml), and the 
highest haptoglobin concentration on day 5 (6.37 mg/ml). WBC was lower on day 
5 than prior to surgery. but within the reference interval in both measurements. 
In Horse 34 (control), which was febrile in the evening after surgery and in the 
morning of the fifth day after surgery, a score of 1 point was given for skin 
temperature on the day after surgery. The total scores were 0 in the other two 
wound evaluations. The highest SAA concentration (385.0 µg/ml) was 
determined on the day after surgery, and the highest haptoglobin concentration 
on the fifth day (4.86 g/ml) after surgery. The lowest iron concentration was 
observed on day 1 (6.7 µmol/ml). On day 5, the iron concentration also was 
below the reference interval (7.7 µmol/ml). The WBC had almost doubled by the 
fifth day after surgery (11.34 G/l). The horse was discharged clinically healthy on 
day 6 after surgery.  
Except in patients who were febrile on day 0, serum amyloid A concentrations 
were increased in patients during post-operative fever. The iron concentrations 
mostly decreased by the time the fever developed. Of the inflammatory 
parameters studied here, febrile horses showed the least prominent changes in 
haptoglobin concentration.  
In conclusion, 5 of the 59 patients (8%) developed post-surgical temperatures 
above 38.6 °C. A clear relationship to the development of a surgical site was not 
seen. Both patients that developed a septic joint after arthroscopy showed 
normal body temperatures within the five-day study period. Due to the low 
number of horses correlations of febrile body temperatures with the inflammatory 
parameters were not calculated. However, from a descriptive basis, SAA often 
seemed to rise fast and high in fever, accompanied by a decline in iron, whereas 
haptoglobin changes were slight and often seemed to occur with a delay.  
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5 Discussion 
5.1  Discussion of the retrospective study 
5.1.1 Advantages of the retrospective study design 
The retrospective cohort study included 652 equines undergoing elective 
orthopaedic surgical procedures from June 2011 to January 2015. 259 patients 
received perioperative antibiotics, and 393 did not and were used as controls. 
This comparatively large number of cases (MacDonald et al. 1994, Borg and 
Carmalt 2013) was compiled over a period of just 3.5 years. It offered the 
advantage that there were no major changes in surgeons, procedures, or drugs 
used compared to other publications whose data were compiled over a longer 
period of time, for example nine years (Olds et al. 2006). Treated and control 
horses were distributed quite evenly over this time. Significant differences 
between the treated and control group were found regarding age and WBC: the 
younger ones and horses with high WBC received antibiotics more often. 
Furthermore, individual surgeons used perioperative antibiotics significantly more 
often than others. Findings like these are typical confounders in retrospective 
studies. As long as they are detected, their influence on the validity of the results 
needs to be discussed. In the author’s opinion, the fact that antibiotic-receiving 
horses were 5.0 ± 3.9 years old and significantly younger than controls with 7.1 ± 
4.3 years, this difference does not seem big enough to be able to influence the 
results. Concerning the WBC (treated: 8.57 ± 2.58 G/l; control: 7.37 ± 1.98 G/l; p 
< 0.0001), the difference between the groups – though significant – seems not 
likely to have affected the results, especially since mean and standard deviation 
values of the treated group are just slightly above the reference interval (4.9-11.1 
G/l). Overall, even in the subgroups, the relatively high number of cases could be 
assembled due to the retrospective nature of the study and assures reliable 
results.  
5.1.2 Limitations of the retrospective study design 
A typical difficulty in retrospective studies are the doubts about the accuracy of 
the record keeping. Since routine systematic and electronic documentation was 
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introduced in the clinic years before the study period began, this aspect was not 
judged of being of high importance. Only eight cases could not be included due 
to a lack of information. 
Non-systematic evaluation of clinical and laboratory examinations and non-
controlled inter-observer agreement are typical disadvantages of retrospective 
studies, too. Nevertheless, it must be kept in mind that the timeframe of the study 
was comparatively short and that there were no major changes in the team 
during this time. Therefore, many wounds were evaluated by the same observers, 
so possible inter-observer differences seem negligible.  
Probably, several patients were actually at increased risk to develop wound 
complications and, therefore, received perioperative antibiotics – this was 
statistically true for those with high WBC preoperatively. However, most horses in 
the treated group seem to have received antibiotic coverage due to the 
subjective concerns of the responsible surgeon which were not documented and, 
therefore, not available for retrospective analysis. In future clinical trials, 
surgeons should document their reasons for initiating the perioperative 
antimicrobial prophylaxis in detail so that these horses can still be included in the 
statistical analysis. Assuming that these decisions were correct and that the 
chosen antibiotic regime was efficient, the complication rate (1.5% septic arthritis, 
39.1% total incisional complications) would have been higher in the treated group 
if these patients would have been left without an antibiotic cover. On the other 
hand, the fact that 393 patients did not get any antibiotic cover and did not show 
higher complication rates allows the conclusion that at least the routine use of 
antibiotics in all patients undergoing elective procedures does not seem 
justifiable. Future research should focus on parameters which could predict the 
need for antibiotic administration in such procedures.  
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5.2 Discussion of the prospective study  
5.2.1 Advantages of the prospective study design  
The prospective part of the study consisted of a randomised controlled cohort 
study. The aim was to detect a possible effect of amoxicillin and gentamicin, 
given once preoperatively, on the development of post-surgical complications in 
clean orthopaedic surgery in equines. Due to the prospective study design, all 
probands were examined and treated at the same time points and received the 
antibiotics in the same dosages, which makes the surgical wound evaluations 
directly comparable with the laboratory examinations. To the author’s knowledge, 
this is the first prospective clinical study on preoperative antimicrobial prophylaxis 
in this kind of surgery.  
Mostly, the author evaluated the wounds personally, and only 15 patients were 
examined by two colleagues. These two colleagues had the wounds of at least 
five horses at all examination time points evaluated in cooperation with the 
author. Therefore, these two were familiar with the scoring system and due to the 
exactly defined and relatively simple scoring procedure, it is assumed that they 
had judged the wounds like the author would have done it.  
The surgical wounds were evaluated using a score sheet which included 
exudation, swelling, skin temperature, and dehiscence (see chapter 3.2.4). This 
wound evaluation system was developed for the prospective study according to 
the main remarks found in the retrospective analysis. It showed similarities to the 
scoring system that was used in Miller’s dissertation (Miller 2006). She evaluated 
wounds and inflammatory parameters not just after elective orthopaedic surgical 
procedures (arthroscopy and splint bone extraction) but also after laparoscopy 
and castration. Therefore, the wound size and risk of complications in her study 
showed a far wider scope than seen in patients presented here. Miller scored 
exudation according to amount and character, whereas in this study, due to the 
small amounts of secretions absorbed by the wound coverage, the score was 
focused on the character of the exudate. Miller evaluated local pain (max. 3 
points) and swelling (max. 3 points) separately whereas these two parameters 
were combined with a maximum of 3 score points in this study. The assessment 
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of skin temperature in the incision area was alike. In Miller’s study, dehiscence 
was not included in the score.  
The laboratory parameters were measured on the day before surgery, within 30-
60 minutes after the horse regained its standing position after anaesthesia 
(named “directly after surgery”) as well as on the first, third, and fifth day after 
surgery. This is less frequent than in Miller’s dissertation. She determined the 
inflammatory parameters in 24 horses undergoing arthroscopy directly before, 6, 
12, 24, 48, and 72 hours after surgery, and if possible, also seven days after 
surgery (Miller 2006). Jacobsen et al. (2009) determined SAA, iron, and 
fibrinogen before, as well as 1, 2, 3, 5, 7, 9, and 11 days after surgery in 11 
horses that had an arthroscopy. Due to the shorter hospitalization time and the 
intention to evaluate the inflammatory parameters together with the wounds, 
other time points of sample collection were chosen than in the previously 
mentioned studies, so that a direct comparison of the results is not possible 
(Miller 2006, Jacobsen et al. 2009). However, since the samples were taken at 
the same time as the wounds were evaluated, the concentration of the 
inflammatory parameters can be put in direct context with the wound healing. A 
retrospective study evaluating 26 horses with systemic inflammation, 114 horses 
with local inflammation, and 61 healthy horses/horses with non-inflammatory 
disease found significantly higher serum amyloid A concentrations and 
significantly lower iron concentrations in horses with systemic infection than in 
horses with local infections (Hooijberg et al. 2014). 
5.2.2 Limitations of the prospective study design  
In the early days of equine clean orthopaedic surgery, an overall complication 
rate of 8.1% was reported (MacDonald et al. 1994). The incidence of septic 
arthritis, one of the most severe complications following arthroscopy, is naturally 
lower and was reported to be close to 1% (Borg and Carmalt 2013, Olds et al. 
2006). Due to this low post-arthroscopy arthritis rate, calculating the number of 
probands needed to be able to differentiate between treated and control animals 
was based on an assumed overall complication rate of 20%. This complication 
rate included increased swelling, increased skin temperature around the surgical 
incision, exudation, and dehiscence, which were assumed to be caused mainly 
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by bacterial contamination. In order to calculate the number of cases needed to 
be able to differentiate between horses receiving antibiotic prophylaxis and 
controls, our hypothesis was that antibiotic prophylaxis should diminish these 
complications by at least by 12%. With 30 patients in each group, this study has 
a statistical power of 60% and an alpha value of 0.3, which seems acceptable for 
a first controlled study in this area. However, statistically, these values have to be 
seen critically, and the results certainly need assurance by evaluation of higher 
patient numbers. For a statistical power of 80% and an alpha of 0.05, 130 horses 
would have been needed per group. To reach this number, a much longer study 
period would have resulted, which would have included more changes in 
surgeons and more changes in procedures. In summary, despite their relatively 
low power, the results are considered reliable enough, to conclude that the 
overall complication rate in the control group was not higher than in the treated 
group. Certainly, minor possible advantages in the antibiotic-treated group may 
not have shown up due to the relatively low patient numbers. 
Furthermore, after conducting the study, a critical point in its design needs to be 
pointed out: the typical onset of septic arthritis has been reported to be 15-17 
days after surgery (Borg and Carmalt 2013), which indicates that our observation 
period may not have been long enough for detecting this severe form of 
complication. Nevertheless, during the first five days after surgery, other 
complications occur, such as increased swelling or increased skin temperature, 
which can be indicative of developing septic arthritis or other severe surgical site 
infections. Horses showing these signs were monitored closely even after 
finishing the study period. Furthermore, if there would have been any concern in 
the owner or the trainer about the healing of a discharged horse after surgery, 
due to overall intense contact with the clients, the clinic certainly would have 
been informed. Therefore, it seems very unlikely that any complications occurring 
after discharge were missed. 
For a more objective wound evaluation, a blinded observer would have been 
optimal. As the author was responsible for the randomisation of horses and the 
wound evaluations, this was not possible. Furthermore, if antibiotics were 
administered, it was obvious in the patient file, which was open to the author. 
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However, using a clearly defined semiquantitative scoring system as strictly as 
possible should have diminished a bias due to the knowledge which horse was 
treated antibiotically or not. Furthermore, in concurrently examining the horses 
clinically every day and measuring the rectal body temperature, these wound 
evaluations were seen as an important part but have never stood alone in 
assessing possible complications. This supporting information clearly pointed out 
which horses needed to be extensively monitored in particular. In addition to 
randomization and blinding the study, the application of a placebo would have 
completed an optimal study design. Since the antibiotics were applied less than 
one minute prior to inducing general anaesthesia, effects of any manipulation or 
application of a comparable volume, e.g., of 0.9% NaCl were not expected, and 
therefore not pursued.  
5.2.3 Methods of the prospective study 
The number of drop-outs was almost equal in both groups. 9/45 horses in the 
control group (22.5%) and 7/35 horses in the antimicrobial-treated group (20%) 
were randomised but did not finish the planned observation period, and therefore, 
their data were not included. However, these relatively high drop-out rates were 
not considered likely to have diminished the validity of the study results as the 
reasons for any drop-out were unrelated to the surgery and group assignment. 
The surgical incisions of the dropped-out horses were scored using the same 
protocol as for the horses that remained in the study. Extraordinarily high scores 
were not observed in these horses. Furthermore, in horses discharged before the 
end of the 5-day postoperative study period and in case of complicated wound 
healing, it was assumed, that the clinic was contacted by the owner, trainer, or 
even referring veterinarian. Therefore, it seems very unlikely that any form of 
complicated wound healing or even arthritis was missed. The outcome regarding 
the ability of preoperative antibiotics to prohibit post-surgical complications was 
most likely not altered. 
Penicillin and gentamicin are commonly used as prophylactic antimicrobials in 
equine surgery (Southwood 2014). During the study period, due to a production 
shortage, no approved preparation of penicillin for horses was available on the 
German market, so amoxicillin as the sodium salt (Belamox®, bela-pharm, 
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Vechta, Germany) was chosen as an alternative antibiotic with an even broader 
spectrum efficiency. Though penicillin was used as a beta-lactam antibiotic in 
studies comparing different antibiotics in castrates (Haucke et al. 2017) and in 
colic surgeries (Durward-Akhurst et al. 2013), respectively, the use of amoxicillin 
in horses has been described for more than 30 years (Carter et al. 1986, 
Brumbaugh et al. 1999). In this study, as recommended by the manufacturer, the 
dose of amoxicillin (10 mg/kg) in combination with gentamicin in the commonly 
used dosage (6.6 mg/kg) was administered as a single shot immediately before 
inducing general anaesthesia in order to generate high tissue levels at the time of 
the first incision.  
Determining the WBC using the same machine throughout the study would have 
been optimal. However, for the first 46 probands, the LaserCyte® Dx Hematology 
Analyzer (IDEXX Europe B.V., Hoofddorp/The Netherlands) was used. After 
these horses, due to a laboratory machine change in the clinic, the ProCyte Dx® 
Hematology Analyzer (IDEXX Europe B.V., Hoofddorp/The Netherlands) was 
used. The equality of both analysers was tested by comparing sixteen blood 
samples from different horses. A CBC was performed with both machines. A 
correlation factor for WBC of 0.99 was found. Therefore, it was assumed that the 
device change did not affect the WBC data.  
Also, five horses were not operated in Tierklinik Lüsche GmbH but at a different 
location called Sanakena, and their haematology was performed on the day after 
blood collection. To prove that there were no valid differences between the 
haematology values in the same blood sample, a storage experiment of five 
blood samples was performed for which these values were compared by a CBC 
performed directly after blood collection and after having been refrigerated for 
one day. A correlation factor for WBC of 0.99 was found. Presumably, storing the 
blood samples for 24 h at 4 °C did not affect the WBC. 
Laboratory evaluations were missing in six horses due to missing samples. In 
one control horse, haematology and creatinine were not performed on the day 
before surgery. In four horses (3 controls, 1 treated), the inflammatory 
parameters and creatinine values were not determined on the day prior to 
surgery due to a communication problem. On the fifth day after surgery, the 
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leucocytes of one control were determined manually and therefore not 
considered for statistical evaluation. Overall, an influence of these few missing 
values was not assumed, and for statistical purposes, the Wald test was used, 
which allowed an analysis of all available data despite the lacking values.  
Suboptimal preanalytic sample handling might have caused haemolysis in 
43/291 blood samples. Of these, 27 were collected directly after surgery. Due to 
the hectic work environment, the blood was often transferred from the syringe 
into the sample tubes with an attached cannula, what might have caused 
preanalytic haemolysis. The results of four of the samples were not included in 
the statistical analysis as the iron concentration was more than twice as high as 
previously determined. Nevertheless, the results of the iron concentration as 
determined by the other measurements of these horses were included in the 
statistical analysis, and the method of maximum likelihood (Wald) test was 
applied. 
Unfortunately, a significant difference between the treated and control groups 
was detected regarding the NSAID applied. The treated horses received 
significantly more often meloxicam than the controls (p=0.03). Forty-four horses 
did not receive meloxicam because of the higher costs. Fifteen horses were 
intended for human consumption, so an administration of phenylbutazone was 
not an option due to legal reasons. A recent study compared the efficacy of 
meloxicam and phenylbutazone in two experimental pain models in horses. In a 
lipopolysaccharide (LPS)-induced synovitis model, in which synovitis was 
induced in 16 horses by injecting 50 ng of LPS in 0.5 ml Ringer’s solution into 
one intercarpal joint, both meloxicam and phenylbutazone reduced the joint 
temperature compared to a placebo. The inflammatory pain was measured by 
scoring pawing the floor or pointing a foot, movement, position in the stall, ear 
position, and orbital tightening. Regarding lameness, there was no significant 
difference between meloxicam and phenylbutazone, but meloxicam was more 
effective than phenylbutazone in reducing synovitis-associated changes in head 
movement (Banse and Cribb 2017). In the study presented here, neither 
lameness after surgery nor pain on palpation were observed in any of the 
patients. As a systemic inflammatory response, fever was present both in 3 
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horses that received meloxicam and in 2 patients receiving phenylbutazone. The 
total scores were highly variable both in horses treated with meloxicam and 
horses receiving phenylbutazone so that an influence of the NSAID on the score 
points in each group was not assumed.  
Furthermore, in three of the phenylbutazone-receiving horses, suspected 
adverse reactions were seen: two patients showed elevated creatinine levels, 
and one horse was anorectic. After discontinuing the NSAID on the day after 
surgery, the creatinine levels returned to normal limits, and the third horse started 
eating again. In these patients, excessive elevations of the inflammatory 
parameters were not observed, so an effect of the absent non-inflammatory 
medication on wound healing seems implausible. Therefore, it seems reasonable 
to critically evaluate the type and the duration of postoperative analgesia with 
NSAIDs.  
5.3 Advantages of the combination of studies 
The main advantage of the retrospective study is the relatively high number of 
cases that were available. In the prospective study, the main advantage is the 
randomized allocation of the patients to either the application of antibiotics or the 
control group. Further advantages are the standardized medications and wound 
evaluations after surgery. The main disadvantage of the prospective part is the 
limited number of cases, which lowers the statistical power of the study. In the 
retrospective part, the main disadvantages are the inconsistent medications and 
wound evaluations. By performing these two study designs consecutively, an 
attempt was made to find those kinds of complications that could be influenced 
by antibiotics and seen in sufficient numbers to allow a prospective study with 
sufficient statistical power within a reasonable timeframe.  
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5.4 Septic arthritis – discussion of results 
5.4.1 Septic arthritis in the retrospective study 
Weese and Cruz (2009) retrospectively reviewed ninety-seven case files of 
horses undergoing an arthroscopy, of which 95 (98%) received antibiotics. They 
did not report any infectious complications, only one horse showed serous fluid 
dripping from the surgical site (Weese and Cruz 2009). Borg and Carmalt (2013) 
analysed 444 horses undergoing 636 arthroscopies from 2008-2010 without 
antimicrobial prophylaxis. Three joints (0.5%) became septic. This is even lower 
than the rate of 1.5% (7/463) in our total retrospective material. An overall joint 
infection rate of  
1.5% was also reported by Olds et al. (2006), who reviewed 461 patient charts 
after arthroscopies with available follow-up information. In their study, 188 horses 
received perioperative antimicrobials, and 273 did not. One patient developed 
septic arthritis despite getting these drugs (0.5%), and six joint infections 
occurred in the group without antibiotics (1.5%). At first glance, these rates seem 
to be reversed by our findings: 2.53% of infected joints occurred in the 
antimicrobial-receiving group (5/198) and just 0.76% in the controls (2/265). 
Statistically, these differences were not significant. However, since the total 
number of joint infections is low, the meaning of the statistics-based statements 
on the benefits of perioperative antibiotics in arthroscopies remains questionable. 
Our study is the first evaluating mainly Warmbloods (93.6%), whereas Olds et al. 
(2006) have seen mainly Standardbreds (72%) and Thoroughbreds (15%). To 
the author’s knowledge, these two are the only publications evaluating 
perioperative antibiotic use in reasonably large controlled populations. If we put 
together the data of both studies, the results cover a total of 924 horses 
undergoing arthroscopies. Septic arthritis occurred in 1.55% of the patients 
receiving perioperative antibiotics and in 1.49% of the patients who did not. To 
improve the statistical power of such studies, it would be helpful to assemble 
comparable data from many more clinics, even retrospectively. However, these 
data may be biased due to an increased use of antibiotics in horses that are 
considered to be at a higher risk by the responsible surgeon. These reasons 
might not be documented, and therefore, a retrospective analysis might not be 
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able to detect them. In conclusion, the rate of arthritic complications might be 
falsely low in the patients which received antibiotics. On the other hand, the 
retrospectively-assembled data in the controls definitely do not show an 
increased risk of arthritis after arthroscopies in patients which did not receive 
perioperative antibiotic prophylaxis. Therefore, to the best of the author’s 
knowledge, the routine use of antibiotics in uncomplicated elective, non-
suspicious arthroscopies in horses cannot be justified by the available data. 
Readmission due to septic joints after arthroscopy on day 2, 15, and 17 was 
reported by Borg and Carmalt (2013). Furthermore, Olds et al. (2006) reported a 
median time of 20 days of operated horses presented with septic arthritis. The 
first signs of septic arthritis were only observed several days to weeks after 
surgery (Olds et al. 2006). In our retrospective material, three horses developed 
septic arthritis on day 2, and one each on day 2, 5, 6, and 27 postoperatively. 
The delayed onset of joint infection suggests a contamination of the joint at some 
time after surgery (Smith et al. 1982, Bertone 1996). That a pre-/perioperative 
antibiotic treatment can prevent infection from a contamination days after surgery 
is not probable. However, side effects, such as the development of colitis and/or 
bacterial resistance (Weese and Cruz 2009), clearly weigh out the benefits of a 
prolonged antibiotic treatment. Also, in humans undergoing coronary artery 
bypass surgery, a prolonged antibiotic prophylaxis (>48 h) was not only 
ineffective in reducing surgical site infections compared to a shorter protocol (<48 
h) but also increased the antimicrobial resistance (Harbarth et al. 2000). As 
antibiotic resistance is considered to be a worldwide emerging health concern, 
the application of prophylactic antimicrobials in equine clean orthopaedic surgery 
should be reserved for patients at risk of developing a surgical site infection.  
 
5.4.2 Septic arthritis in the prospective study 
In the prospective part of this study on 47 arthroscopies in 36 horses, Horse 30 in 
the control group developed a septic coffin joint on day 8 after surgery, after the 
end of the study observation period (1/47 joints: 2.1%; 1/36 horses: 2.8%). 
Regarding only the controls, the rate of septic joint development would be 4% 
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(1/25 arthroscopies). With an antibiotic cover, none of the 22 joints in the 17 
horses involved showed such a complication. However, the excluded Horse 39, 
initially randomised into the treatment group, developed a septic coffin joint 
despite receiving the routine amoxicillin/gentamicin combination preoperatively 
and additional gentamicin for two days after the arthroscopy. This dropped-out 
horse emphasizes the importance of including a sufficient number of horses in 
order to produce valid recommendations. The number of horses undergoing 
arthroscopies in the prospective part of this study is definitely not sufficient to 
allow conclusions on the usefulness of antibiotics in preventing septic joints. The 
aim of this study was to compare the incidence of all wound complications, which 
– based on the retrospective data – are estimated to occur in 39.1% of cases. 
Furthermore, it must be mentioned that Horse 39 succeeded several times in 
biting off its bandage despite the distal fixation with an adhesive bandage and a 
cover with “unpalatable” paste (AKS, Horse fitform AKS Verbiss-Stop, flüssig 1l, 
PHARMAKA GmbH & Co. KG, Essen, Germany). Therefore, the arthroscopy 
portals to the coffin joint were exposed to the environmental and possibly faecal 
germs. Typically, the pathogens found in equine surgical incisions are β-
haemolytic streptococci, staphylococci, enterobacteriaceae, and Pseudomonas 
spp. (Ahern and Richardson 2011). These are saprophytes, and in the case of 
enterobacteriaceae, also faecal bacteria (Bauerfeind 2010, Wieler et al. 2010) 
which are ubiquitous in the horses’ surroundings. Gram-positive cocci are 
regularly found on the skin and the mucous membranes of healthy individuals 
(Valentin-Weigand 2013). As the onset of the septic arthritis was 8 or 9 days after 
surgery, respectively, in our study material, the observation period of five days 
was probably not long enough in this aspect, which is underlined by other 
retrospective studies (Olds et al. 2006, Borg and Carmalt 2013) and the 
retrospective material of this project. Nevertheless, the horses were continuously 
monitored either by the clinic or the owner/trainer, who with a very high 
probability would have contacted the clinic in any case of complications. 
Therefore, it is unlikely, that septic arthritis was missed in any of the patients. 
Furthermore, surgical site infections are defined to occur within 30 days after the 
surgical procedure if no implant was placed and within a year when an implant 
remains in the body (Waguespack et al. 2006). It was already hypothesized that 
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the contamination of operated joints can occur at some point after surgery (Smith 
et al. 1982). Therefore it seems very unlikely that preoperative application of 
antibiotics as a single shot will prevent any infections occurring at some point 
after surgery. It needs to be emphasized, that after discharge after arthroscopy, a 
joint may still develop an infection and then requires intensive therapy 
immediately (Orsini 2017). 
5.4.3 Conclusion 
In neither the retrospective nor the prospective part of this project, nor in other 
retrospective studies (Olds et al. 2006), a reduction of the incidence of post-
operative septic arthritis after equine arthroscopy by perioperative antimicrobial 
prophylaxis was demonstrated. Borg and Carmalt (2013) report post-operative 
septic joints in 0.5% of the joints and in 0.7% of the horses after 444 arthroscopic 
procedures without perioperative antimicrobial prophylaxis. To the best of the 
author’s knowledge, no other controlled studies examining the efficacy of pre-
/perioperative antimicrobial prophylaxis exist. Even if the arthritis rate in the 
antibiotic-receiving horses might be falsely low, the overall low incidence in 
controls should lead to the recommendation to not use perioperative antibiotics 
out of habit. The conscious decision to use or not use antibiotics in each case 
should become routine. Surprisingly, even in horses treated with antibiotics, a 
late onset of septic arthritis is sometimes seen. This warrants the careful 
evaluation of the patient (by the informed owner) in all cases for about four 
weeks postoperatively.  
5.5 Incisional abnormalities - discussion of results  
5.5.1 Incisional complications in the retrospective study 
MacDonald et al. (1994) published a retrospective study on the occurrence of 
wound infections in 452 equine orthopaedic surgical cases. They described a 
complication as an infected wound, which meant purulent discharge, 
spontaneous dehiscence, erythema as well as pain and swelling in the 
“immediate” post-operative period (which was not clearly defined). An overall 
wound infection rate of 10.0% was found in their material. If just the clean 
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surgeries were considered, the rate was reduced to 8.1%. Surprisingly, even 
after a multivariate analysis, they found a 4.6 times higher risk of developing 
wound infections in patients which were treated with preoperative antibiotics. The 
authors explain this phenomenon with the ability of surgeons to correctly identify 
the risk factors, e.g. the difficulty and amount of trauma associated with the 
procedure. This might have resulted in the decision to cover high-risk patients 
with antimicrobials preoperatively (MacDonald et al. 1994). In the retrospective 
study part presented here, complications were listed in more detail and – besides 
joint infections – comprised seroma, any kind of wound discharge, moderate and 
severe swelling as well as a body temperature higher than 38.5°C. This explains 
our high overall complication rate of 39.1% in 652 patients with clean surgical 
procedures, which exceeds the above-mentioned 8.1% by far. Despite this more 
detailed data collection, including increased wound swelling – and therefore 
probably higher percentages in our data – there was no clinically or statistically 
relevant decline in complication rates in patients that received perioperative 
antibiotics compared to controls that did not (p=0.5).  
5.5.2 Incisional complications in the prospective study 
In the prospective part of the project, the total wound evaluation score was 
significantly higher in the treated than the control patients on day one (p=0.03) 
and day five (p=0.01). Randomly allocated, antibiotic-receiving horses showed 
significantly higher scores for local swelling (on days one and five) and skin 
temperature (on days one and three). Admittedly, overall and even initial wound 
scores were quite low, and scores for swelling as well as skin temperature 
decreased significantly during the observation period in both groups. 
Furthermore, there were no significant differences in exudation and dehiscence 
between the treated and control patients. At this point, it seemed to be important 
to mention that the study was not blinded, and therefore, a bias of the examiner 
cannot completely be excluded. However, a systematic influence was avoided to 
the best of the author’s knowledge by defining the strict criteria for score point 
assignment before the start of the study and by enhancing the awareness of a 
possible bias.  
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MacDonald et al. (1994) assumed in their retrospective analysis that the 
significantly higher risk of developing surgical site infections under antibiotic 
cover was caused by the identification of additional risk factors by the 
responsible surgeon. Despite the antibiotic cover, those high-risk patients 
remained to have an increased risk of complications – which would even be 
higher if they had not received antibiotics. However, the prospective study 
presented here was randomised. Therefore, the horses in both groups should 
have had the same risk of developing surgical site infections. To the knowledge 
of the author, this is the first prospective controlled study that evaluated local 
reactions after performing elective orthopaedic surgical procedures in equines. 
The results show that the healing process in the control group was certainly not 
inferior in comparison to the group receiving “prophylactic” antibiotics. 
5.5.3 Conclusion 
Taken together, the results of MacDonald et al. (1994) and the retrospective and 
prospective studies presented here, show that there are no advantages evident 
in patients that received perioperative antimicrobial prophylaxis compared to 
controls that did not. The general application of these drugs in equine 
uncomplicated elective, clean orthopaedic surgery is not justifiable by the 
available data. In our prospective study, the “one-shot” preoperative amoxicillin 
and gentamicin failed to reduce post-surgical complications. A routine 
preoperative application of antimicrobials in this type of surgery does not seem 
necessary. The administration of antimicrobial pro- or metaphylaxis in equine 
uncomplicated, clean elective surgery requires an individual assessment of risks 
and benefits, which should include surgical and postoperative findings. 
Additionally, these findings substantiate the German guidelines for antibiotic use 
in animals, which recommend the antibiotic prophylaxis for horses only in long 
and complicated surgeries (Bundestierärztekammer 2015).  
5.6 Fever – discussion of results 
In a retrospective study of human orthopaedic trauma patients suffering from 
closed (88%) or open (4%) fractures, and soft tissue injuries (8%), 106/582 
(18.2%) developed a fever in the early postoperative period which was defined 
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as five days after surgery. All patients received perioperative antibiotics for 24 
hours, commencing at the time of surgery. It was not precisely specified when 
the last dose of antibiotics was given. Median onset of fever after surgery was 14 
hours (range 8-32 hours) and the mean duration was 9 hours with a standard 
deviation of 11 hours. In 59/106 febrile patients, 110 diagnostic tests were 
performed, including bacterial culture of urine (n=31), blood (n=30), or wound 
exudate (n=1) as well as urine biochemical analyses (n=28) and chest 
radiographs (n=20). Bacterial causes of the fever were identified in 12% of the 
tests (1 blood and 3 urine cultures, 7 urine analyses, and 2 radiographs). It was 
assumed in almost all cases that the fever was not caused by a bacterial 
infection, but by an elevation of inflammatory parameters after trauma and 
surgery (Petretta et al. 2013). 
In our retrospective study of elective orthopaedic surgical cases, 30/652 horses 
(4.6%) developed a fever during their hospitalization. Of these, 8/30 (26.7%) 
already showed temperatures above 38.5°C on the first day after surgery, and 
nine were febrile at the second day. Only one patient with fever (on day 6) 
developed septic arthritis on the same day. However, none of the patients in the 
retrospective part of the project with fever in the early post-operative period (2-5 
days) developed further signs of a systemic infection. Nonetheless, due to the 
fear that an elevated body temperature might be caused by bacteria, antibiotic 
treatment was initiated in 14 of our feverish 25 control horses of the retrospective 
study. Knowing nowadays that a rise in body temperature might just be caused 
by a postsurgical increase in inflammatory parameters, the antibiotic use is 
questionable at the least. Certainly, horses with a postoperative fever should be 
particularly carefully checked for signs of infection as it is done in the prospective 
part of the study. However, to the author’s knowledge, no systematic studies 
exist on the development or causes of postoperative fever after clean 
orthopaedic surgery in equines. A prospective study regarding the duration and 
degrees of body temperature after these procedures could help in differentiating 
between purely inflammatory and septic causes. 
In the prospective part, a well-comparable percentage of horses (5/59; 5.5%) 
developed such an elevated body temperature within the five observation days. 
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Four belonged to the control group (n=31; 12.9%) of which only one (Horse 16) 
also developed a surgical site infection (2 dehiscent sutures at the distal edge of 
the incision). Only one patient in the treatment group (n=28; 3.6%) developed a 
fever. Two control horses (Horse 3, horse 32) received antibiotic treatment due to 
the fever and recovered without further complications. A post-operative 
monitoring of the horses and antibiotic treatment of patients identified to be at 
risk seems to be sufficient. Four controls and just one treated horse developed 
fever in the prospective study; the number of patients, however, does not seem 
large enough to evaluate this difference statistically. However, in our 
retrospective material, 25 controls and just 5 treated horses showed 
postoperative fever. Therefore, a close observation of the body temperature for 
at least 28 days postoperatively is strongly recommended.  
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5.7 Inflammatory parameters 
5.7.1 Inflammatory parameters after clean elective orthopaedic 
surgery in horses 
In our study, Serum Amyloid A, iron, haptoglobin, albumin and globulin as well as 
the WBC were determined as inflammatory parameters in the horse. Miller (2006) 
evaluated inflammatory parameters in equines after different types of surgery. In 
a subgroup of 24 horses undergoing an elective arthroscopy, the SAA peaked 48 
hours after the procedure (210.4 ± 147.7 μg/ml). After seven days, the SAA 
concentrations were back in the reference interval (Miller 2006). Another study 
confirmed an inflammatory response after arthroscopy in 11 equines. Already on 
the first day after surgery, significantly higher SAA levels were found than 
preoperatively. Initial levels were reached five days after surgery (Jacobsen et al. 
2009). Neither of these publications specifies the perioperative prophylactic 
treatment with antimicrobials. In our study, the SAA concentration was not 
measured as frequently as in the other studies. The SAA peak seems to occur 
around the same time as in Miller`s study: In our treated group, the individual 
concentrations peaked between day 1 and 3, in the control group the peak 
occurred at a later timepoint, between day 3 and 5. To the best of the author’s 
knowledge, the study presented here is the first to compare post-surgical 
inflammatory parameters with and without antimicrobial prophylaxis in horses. 
Comparing the treated and the control patients, in the antibiotic-receiving group, 
the SAA levels returned to their initial concentrations within the observation 
period of 5 days, whereas in the control group, the decline of the SAA 
concentration started on day 3 but did not reach the initial levels even by day 5. 
Also, the SAA concentration seems relatively, though not significantly, higher in 
the control than in the treated group. This could be either caused by an additional 
anti-inflammatory effect of the antibiotics as described for tilmicosin, a macrolide 
antibiotic (Buret 2010). However, to the best of the author’s knowledge, such 
effects were not described for either amoxicillin nor gentamicin so far. On the 
other hand, it is possible that the controls had higher SAA concentrations than 
the treated horses because of bacterial contamination during the surgery which 
was not prevented by antibiotics. This seems nonetheless unlikely, as more 
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treated than control horses developed a surgical site infection. An influence of 
the NSAID cannot be completely excluded, as 11/28 treated and only 4/31 
control horses received meloxicam instead of phenylbutazone. A recent study 
compared the efficacy of phenylbutazone and meloxicam in reducing 
inflammation-induced pain. The only difference between the two agents was that 
meloxicam was more effective reducing synovitis-induced head movement 
(Banse and Cribb 2017). 
A significant decrease in the serum iron concentration was seen in 11 horses 
undergoing arthroscopy (p<0.0001), however, it returned to baseline on day two 
(Jacobsen et al. 2009). During our 5-day-long observation period, there was no 
significant difference between treated and control horses in serum iron 
concentration (p = 0.76), but there was a significant change in the iron 
concentration. Furthermore, similar to Jacobsen’s study, a low serum iron 
concentration was determined directly after surgery, which went back to the initial 
concentrations already on day 1 after surgery. For using iron as a marker for 
inflammation/infection after surgery, more horses with such sequelae need to be 
examined – possibly they could be detected by continuously low iron levels.  
In Miller’s study, 48 hours after arthroscopy (n=24), there was a slight increase in 
the haptoglobin concentration (2.9 ± 1.5 mg/ml), which developed into a decisive 
augmentation after 72 hours (3.2 ± 1.6 mg/ml, Miller 2006). In our study, the 
serum haptoglobin concentration changed significantly over time (p<0.0001). The 
haptoglobin values on day three and five were generally, although not 
significantly, higher than at the previous measurements prior to, directly after, 
and on the day after surgery. However, in 14/59 horses, the initial haptoglobin 
concentrations were already above the reference interval before surgery. 
Therefore, it remains unclear whether an increase in serum haptoglobin 
concentration postoperatively can be a valuable indicator of 
inflammation/infection in a horse.  
Jacobsen et al. (2009) reported a significantly higher WBC on day 1 than the 
preoperative baseline levels (p<0.01) and significantly lower levels on day 5 after 
surgery (p<0.01). From day 6 on, the WBC was back at the baseline level. In our 
study, the WBC was also significantly lower on day 5 than before surgery, but not 
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to a clinically relevant extent. Neither of the horses with a WBC below 4.0 G/l 
developed a surgical site infection. However, 1/5 horses with a WBC >11.0 G/l 
developed a septic joint. Of course, there were not enough horses included into 
the study to make a statistically valid statement. However, according to the 
results, WBC changes are not seen regularly with SSI.  
5.7.2 Inflammatory parameters in horses with surgical site infections 
In the prospective study, decisive changes in inflammatory parameters were 
observed just in horse 30 that developed septic arthritis on day eight. In this 
horse, the course of serum amyloid A and iron suggested the onset of an 
inflammation. In this patient, the SAA concentration increased steadily until day 
five to 1565.6 µg/ml, and the serum iron concentration declined continuously. 
Retrospectively, the intense and prolonged post-surgical inflammatory response 
in horse 30 may have suggested the beginning inflammation of the joint. In order 
to detect imminent danger of a severe surgical site infection, the findings in this 
horse suggest that a control of SAA five days postoperatively might be useful, 
since in patients with uncomplicated healing after surgery this parameter should 
have returned to normal limits by then.  
In Horse 39 which received additional gentamicin (excluded) and developed 
post-surgical septic arthritis nine days after surgery, however, the serum amyloid 
A concentration did not show a pronounced increase. On the day after surgery, it 
hardly exceeded the reference interval and returned to baseline levels on day 
three. On the day of surgery and on day one, the iron was below the reference 
interval in this horse. On the one hand, this mild change in inflammatory 
parameters could be a laboratory measurement error. On the other hand, it could 
also underline the theory that the infection of the joint often occurs at some point 
after the surgery (Smith et al. 1982, Bertone 1996). This is also supported by the 
observation that this horse repeatedly removed its bandage despite all 
precautions.  
The presurgical SAA levels of Horse 64 (two dehiscent sutures on day one) 
showed an almost 300-fold elevation. This concentration then declined steadily. 
The lowest iron concentration in this patient was measured on the day after 
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surgery. Its highest haptoglobin concentration was determined directly after 
surgery. An infection in a remote site of the body was defined as a patient-
associated risk factor of the development of SSI in humans (World Health 
Organization 2009, Wacha et al. 2010, Bratzler et al. 2013). In Horse 64, the 
elevated serum amyloid A concentration prior to surgery suggested the presence 
of a clinically inapparent inflammation - possibly caused by an infection. 
Therefore, this patient was at risk of developing a surgical site infection. A 
preoperative assessment of the inflammatory parameters can reveal subclinical 
infections and may help minimize the development of surgical site infections. The 
pre- and postoperative monitoring of serum amyloid A, for which a portable test is 
available (Stablelab SAA test, exact results with the Stablelab EQ-1 Handheld 
Reader, Stablelab, Sligo, Ireland), seems for a preoperative risk assessment, 
even though just 2/8 horses with elevated preoperative SAA concentration 
developed a surgical site infection in the study presented here. Therefore further 
research seems warranted to identify and describe risk factors for SSI 
development in horses. 
Except for the joint infections in horses 30 and 39, all patients responded well to 
local treatment. Significant differences in serum amyloid A have been reported as 
well as in the serum iron levels between horses with local and systemic infections 
(Hooijberg et al. 2014), which explains why the other four horses might not have 
shown major changes in the inflammatory parameters. Except for horse 39, the 
inflammatory response in our patients with surgical site infections also reflected 
its severity. The inflammatory parameters in horse 39, however, did not suggest 
the development of a septic joint during the first five days after surgery. 
Nevertheless, inflammatory parameters alone are no reliable assessment for 
differentiation between systemic and local inflammation (Hooijberg et al. 2014). 
Surgical patients with suspicious clinical findings and/or whose SAA levels are 
constantly rising and have declining serum iron levels, require further intense, 
precise, and frequent clinical and laboratory examinations in order to initiate an 
appropriate therapy if necessary. The regular additional monitoring of 
inflammatory parameters in post-surgical patients can be used complementarily 
in horses after clean, elective orthopaedic surgery to detect surgery-associated 
complications early. 
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5.7.3 Inflammatory parameters in horses with post-surgical fever 
In a recent study on 582 human orthopaedic trauma patients suffering from 
closed (88%) and open (4%) fractures, or soft tissue injuries (8%), 106/582 
(18.2%) developed post-operative fever. In these patients, a preoperative 
increase in inflammatory cytokines, which was initiated by the trauma and was 
further increased by the surgical procedures, was assumed to be the cause of 
the fever in the study of human orthopaedic trauma patients (Petretta et al. 2013).  
A similar phenomenon was also observed in the five (4 controls, 1 treated) febrile 
patients, of which just one control developed a surgical site infection, in the 
prospective study: the temperature peaks were seen at the same time when the 
serum amyloid A concentration increased and the serum iron concentration 
declined. In febrile patients. already directly after surgery and at all 
measurements following, the SAA level was higher than the median SAA 
concentration. From day 1 after surgery onwards, the serum iron concentration in 
febrile patients was below the median iron concentration, except in horse 3 which 
was febrile on both temperature measurements on day 2 and therefore received 
trimethoprim-sulfadiazine. In horse 3, the iron concentration was below the 
median iron concentration from day 3 onwards. Therefore, it is very well possible 
that the fever resulted from an increased inflammatory response due to surgery.  
High haptoglobin concentrations, however, were not associated with increasing 
temperatures. It is therefore questionable whether haptoglobin is a valid 
parameter for measuring the inflammatory response in surgical patients.  
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6 Summary 
This dissertation comprises a retrospective analysis of patient files and a 
randomised, prospective clinical study of postoperative complications in equines 
after clean orthopaedic surgical procedures. The main aim of these studies was 
to evaluate possible differences between horses pre-treated with antibiotics and 
those not having received these drugs.  
For the retrospective part, 652 out of the 684 case files were suitable for 
statistical analysis. Details were compiled on the patients, the surgical procedure, 
and the surgery-associated complications. Antibiotic-receiving patients (n=259) 
were statistically compared to controls (n=393) by employing the Fisher-
Freeman-Halton test or an ANOVA. The main parameter was the development of 
postoperative complications. For the post hoc analysis, Fisher’s exact test and 
the Wilcoxon-Mann-Whitney-test were used. The overall complication rate in the 
retrospective study was 39.1%. An increased incisional swelling was observed 
most often (25.6%), followed by exudation (7.5%), fever (2.3%), dehiscence 
(1.8%), and seroma in five cases (0.8%). Septic arthritis was documented in 
7/463 horses (1.5%) undergoing arthroscopies. There were no significant 
differences detected in the development of postoperative complications between 
the 97/259 (37.5%) antibiotic-receiving patients and in the 158/393 (40.2%) 
controls. The application of perioperative antibiotics was significantly influenced 
by the surgeon (p<0.0001), type of surgery (p=0.0007), and increased with the 
number of surgical lesions (p=0.03). Antibiotic-receiving patients were treated for 
3-5 days after surgery and most of them received penicillin-based antibiotics. 
Patients with three or more interventions per session (n=30) received antibiotics 
significantly more often. In patients undergoing tendovaginoscopy/bursoscopy, 
fasciotomy, and neurectomy (n=98), antibiotic prophylaxis was initiated less 
frequently than in the other surgeries, e.g., combinations of surgeries, splint bone 
extraction, tenotomy, and arthroscopy (n=554). 
In the prospective clinical study, 75 horses were assigned randomly to either the 
antibiotic-receiving (treated) or the control group. Treated horses received 10 
mg/kg amoxicillin and 6.6 mg/kg gentamicin once directly before inducing general 
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anaesthesia. These horses were intensely monitored for five days. Using a 
semiquantitative scoring system for swelling, skin temperature, exudation, and 
dehiscence, the surgical wounds were assessed on the days one, three, and five 
after surgery. In addition, the inflammatory parameters SAA, iron, and 
haptoglobin were determined on the day before, directly after, and on days one 
three and five after the surgery. Differences between the groups in score points, 
rectal body temperature, concentrations of inflammatory parameters, and patient 
characteristics were tested by the Fisher-Freeman-Halton test or the 
ANOVA/Wald test. For the post hoc analysis, Fisher’s exact test and the 
Wilcoxon-Mann-Whitney test were used. 
Total score (p=0.002), the scores for swelling (p=0.002), and skin temperature 
(p=0.007) were significantly higher in the treated group than in controls. The post 
hoc analysis identified a significantly higher total score for the treated horses on 
day 1 (p=0.02), and 5 (p=0.01), which was mainly due to swelling with 
significantly higher scores on days 1 (p=0.02) and 5 (p=0.002), too. On day 1 
(p=0.04) and 3 (p=0.03), the score points for skin temperature were significantly 
higher in the treated horses. Four horses in the control group and just one 
treated developed fever. There was no significant difference between the groups 
in SAA (p=0.18), serum iron (p=0.76), and haptoglobin (p=0.85) concentrations. 
Two horses (1 control, 1 treated drop-out), of which the treated one dropped out 
of the study because of postoperative additional gentamicin administration, 
developed a septic joint eight and nine days after surgery, respectively. Such 
severe complications in equine clean orthopaedic surgery are rare, whether 
having received perioperative antibiotics or not. In summary, the use of 
perioperative antibiotic prophylaxis in uncomplicated, elective orthopaedic 
surgical procedures in equines cannot be justified based on these data. 
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7 Zusammenfassung  
Untersuchungen zur prä- oder perioperativen Antibiotika-
Prophylaxe bei aseptischen, elektiven orthopädischen Eingriffen 
an Pferden 
Dieses Dissertationsprojekt beinhaltet eine retrospektive Analyse und eine 
randomisierte, prospektive klinische Studie zu postoperativen Komplikationen bei 
Pferden nach sauberen, elektiven orthopädischen Eingriffen. Ziel beider Studien 
war es zu untersuchen, ob Unterschiede zwischen antibiotisch (vor-)behandelten 
und nicht mit Antibiotika behandelten Tieren (Kontrolle) hinsichtlich der 
Entwicklung postoperativer Komplikationen bestehen. Für den retrospektiven Teil 
konnten aus 684 Patientenakten 652 Fälle eingeschlossen werden. Einzelheiten 
zum Signalement, chirurgischen Eingriffen und OP-assoziierten Komplikationen 
wurden extrahiert. Mittels Fisher-Freeman-Halton-Test oder ANOVA wurde 
statistisch geprüft, ob Unterschiede zwischen mit Antibiotika behandelten 
Patienten (n=259) und Kontrollen (n=393) bestanden. Als post-hoc Tests wurden 
Fisher’s Exact Test und der Wilcoxon-Mann-Whitney Test verwendet. Insgesamt 
traten bei 39,1% der Pferde in der retrospektiven Studie postoperative 
Komplikationen auf. Vermehrte Schwellung (25,6%) war die häufigste 
Komplikation, gefolgt von Exsudation (7,5%), Fieber (2,3%), Dehiszens (1,8%), 
septischer Arthritis [bei 463 arthroskopierten Patienten (1,5%)] und einem Serom, 
das bei fünf Patienten auftrat (0,8%). Signifikante Unterschiede in den OP-
assoziierten Komplikationen zwischen antibiotisch behandelten Patienten 
(97/259) und Kontrollen (158/393) wurden nicht nachgewiesen. Die Gabe von 
perioperativen Antibiotika wurde signifikant vom Chirurgen (p>0,0001), der Art 
der Operation (p=0,0007) und der Anzahl chirurgischer Eingriffe pro Sitzung 
beeinflusst (p=0,03). Mit Antibiotika behandelte Pferde erhielten 3-5 Tage lang 
Antibiotika. Am häufigsten wurden Penicillin-basierte Wirkstoffe eingesetzt. 
Patienten mit drei oder mehr Eingriffen (n=30) erhielten signifikant häufiger 
Antibiotika. Perioperative Antibiotika wurden seltener bei 
Tendovaginoskopie/Bursoskopie, Fasziotomie und Neurektomie (n=98) als bei 
Kombinationen von Eingriffen, Griffelbeinextraktionen, Desmotomie und 
Arthroskopie (n=554) gegeben.  
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Für die prospektive Studie wurden 75 Pferde, die für einen elektiven 
orthopädischen EIngriff in der Klinik vorgestellt wurden, randomisiert entweder 
der Antibiotika-Gruppe oder der Kontroll-Gruppe zugeordnet. Antibiotisch 
behandelte Pferde erhielten einmalig 10 mg/kg Amoxicillin und 6,6 mg/kg 
Gentamicin vor der Einleitung der Narkose. Diese 75 Pferde wurden über 5 Tage 
intensiv überwacht. Mittels eines Scores wurden Schwellung, Hauttemperatur, 
Exsudation und Dehiszens am ersten, dritten und fünften Tag nach dem Eingriff 
beurteilt. Zusätzlich wurden am Tag vor, direkt nach sowie einen, drei und fünf 
Tage nach der Operation die Entzündungsparameter SAA, Eisen und 
Haptoglobin bestimmt. Die beiden Patientengruppen wurden auf Unterschiede in 
den Scorepunkten, Körpertemperatur, Konzentrationen der 
Entzündungsparameter und Patientencharakteristika mit dem Freeman-Halton-
Test oder ANOVA/Wald-Test geprüft. Als post-hoc-Tests wurden Fisher’s Exact 
Test und der Wilcoxon-Mann-Whitney-Test verwendet. Der Gesamtscore 
(p=0.002), die Scores für Schwellung (p=0.002) und Hauttemperatur (p=0.007) 
der antibiotisch behandelten Tiere waren signifikant höher als bei den Kontrollen. 
In der Post-hoc Analyse war der Gesamtscore bei behandelten Tieren an Tag 1 
(p=0.02) und fünf (p=0.01) signifikant höher als bei den Kontrollen, ebenso wie 
der Score für Schwellung an Tag 1 (p=0.02) und 5 (p=0.002), sowie der Score für 
Hauttemperatur an Tag 1 (p=0.04) und 3 (p=0.03). Weder in der SAA- (p=0.18), 
noch in der Eisen- (p=0.76) oder Haptoglobin-Konzentration (p=0.85) gab es 
signifikante Unterschiede zwischen den Gruppen. Zwei Pferde (1 Kontrolle, 1 
Drop-out) entwickelten ein septisches Hufgelenk. Das ausgeschlossene 
antibiotisch behandelte Pferd entwickelte an Tag 9 nach dem Eingriff ein 
septisches Hufgelenk trotz einer zusätzlichen Behandlung mit Gentamicin an Tag 
1 und 2. Bei dem Kontrollpatienten trat die septische Arthritis an Tag 8 auf. 
Schwere postoperative Komplikationen bei sauberen orthopädischen Eingriffen 
beim Pferd sind selten. Die Inzidenzen schwerer Komplikationen bei Patienten 
mit und ohne perioperative Antibiose unterschieden sich nicht statistisch 
signifikant. Zusammenfassend lässt sich anhand der vorliegenden Daten ein 
grundsätzlicher Einsatz von Antibiotika bei unkomplizierten, elektiven 
orthopädischen Eingriffen beim Pferd nicht rechtfertigen.  
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A 
Appendix 
Minimum, 1st and 3rd quartile, median, and maximum for score 
points in treated and control horses  
Scores for exudation 
  Treated (n=28) Control (n=31) 
  Day 1  Day 3 Day 5 Day 1  Day 3 Day 5 
Minimum 0 0 0 0 0 0 
1st quartile   0 0 0 0 0 0 
Median 0 0 0 0 0 0 
3rd quartile 0 0 0 0 0 0 
Maximum  1 1 3 1 1 1 
 
 
Scores for swelling 
  Treated (n=28) Control (n=31) 
  Day 1  Day 3 Day 5 Day 1  Day 3 Day 5 
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 
1st quartile   1.0 1.0 0.0 0.0 0.0 0.0 
Median 1.0 1.0 1.0 1.0 1.0 0.0 
3rd quartile 1.5 1.5 1.0 1.0 1.0 1.0 
Maximum  2.0 2.5 3.0 2.0 1.0 1.0 
 
  
B 
 
Scores for skin temperature 
  Treated (n=28) Control (n=31) 
  Day 1  Day 3 Day 5 Day 1  Day 3 Day 5 
Minimum 0 0 0 0 0 0 
1st quartile   0 0 0 0 0 0 
Median 1 1 0 0 0 0 
3rd quartile 1 1 1 1 1 0 
Maximum  2 2 2 1 1 1 
 
 
Scores for dehiscence 
  Treated Control 
  Day 1  Day 3 Day 5 Day 1  Day 3 Day 5 
Minimum 0 0 0 0 0 0 
1st quartile   0 0 0 0 0 0 
Median 0 0 0 0 0 0 
3rd quartile 0 0 0 0 0 0 
Maximum  3 3 3 0 0 1 
  
C 
P-values for the wound scores on day 1, 3, and 5  
Parameter  Day P 
Exudation  
1 0.9 
3 0.8 
5 0.8 
Swelling 
1 0.02 
3 0.1 
5 0.002 
Skin temperature  
1 0.04 
3 0.03 
5 0.2 
Dehiscence 
1 0.2 
3 0.2 
5 0.5 
Total Score  
1 0.02 
2 0.02 
5 0.01 
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